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ABSTRACT
Since December 2019, the coronavirus disease 2019 (COVID-19) has swept across the world,
infecting and killing millions of people, making it one of the worst pandemics in history (WHO,
2021). However, the rates of confirmed cases and deaths have slowed since the discovery of
the COVID-19 vaccine. The purpose of this evidence-based practice (EBP) project was to
decrease vaccine hesitancy and increase uptake of the COVID-19 vaccine in the family care
setting. The Iowa Model-Revised (Iowa Model Collaborative, 2017) is a practical, effective multistep change process that acted as a guide for the EBP project. A review of literature showed
that written patient reminders, electronic patient reminders, education provided to patients and
education provided to healthcare providers (HCPs) were effective interventions to increase
vaccine uptake. The EBP project’s multimodal intervention consisted of an educational session
with HCPs in the clinic, informational brochures, and vaccine reminder cards given to patients
during their visits to the clinic. All adults 18 years of age and older who sought care in a
Northern Indiana family care clinic during the 10-week implementation period received the
intervention. COVID-19 vaccination status was the outcome of interest and was assessed by
reviewing electronic chart records. Patients who had not yet received a dose of the COVID-19
vaccine at baseline were followed up with four weeks later to assess their post-intervention
vaccination status. Reviewing the electronic chart records initially and then placing telephone
calls to obtain the remaining records accomplished data collection. Frequency, expressed as a
percentage, was calculated to evaluate the change in COVID-19 vaccination rate and thus the
success of the intervention. The EBP project found a 5.6% increase in the COVID-19
vaccination rate among participants 4 weeks after being exposed to the multimodal intervention.
Although there was an increase in vaccination rate, it was not large enough to represent a
statistically significant result (RR = 0.969). Therefore, the multimodal intervention was not
effective at decreasing vaccine hesitancy and increasing uptake of the COVID-19 vaccine and
future research and EBP projects are needed on the topic.
ix

CHAPTER 1
INTRODUCTION
Background
Since December 2021, the coronavirus disease 2019 (COVID-19) has swept across the
world, infecting and killing millions of people (World Health Organization [WHO], 2021). The
COVID-19 outbreak is considered one of the worst pandemics in global history. There are
many different types of coronaviruses, which are named for the crown-like spikes present on the
surface of the virus, but the one responsible for the COVID-19 pandemic is called severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) (CDC, 2020). COVID-19 was discovered in
Wuhan, China in December 2019 and, due to its contagious nature, quickly spread to the rest of
the world (CDC, 2021 May 24). The disease is transmitted when one person excretes droplets
and particles that contain the virus, either by coughing, sneezing, or breathing, and then another
person in the near surrounding assimilates the droplets into their mouth, nose, or eyes (CDC,
2021 May 13). Therefore, the lack of containing coughs and sneezes, touching contaminated
surfaces, and attending crowded events with absence of social distancing spreads of the
disease. COVID-19 can cause a wide variety of symptoms, including fever, cough, difficulty
breathing, fatigue, body aches, headache, sore throat, loss of smell or taste, nasal congestion
or drainage, nausea, vomiting, and diarrhea (CDC, 2021 February 22). The disease burden
ranges from mild and self-limiting to severe and life threatening, depending on the infected
individual.
As of April 27, 2022, the Centers for Disease Control and Prevention (CDC) have
reported a total of 80,874,929 confirmed cases of COVID-19 in the United States (U.S.), which
have resulted in 988,991 deaths (CDC, 2022 April 27). The rates of confirmed cases and
deaths have slowed since the discovery of the COVID-19 vaccine. As with other vaccines, the
body produces special memory cells, called T-lymphocytes and/or B-lymphocytes, which assist
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the body in fighting the virus when confronted with it (CDC, 2021 May 27). Although this same
defense mechanism is present in the new COVID-19 vaccine, many people are hesitant and
have not received their dose(s) of vaccine. The CDC (2022, April 27) reports that, as of April
27, 2022, 219,550,028 people in the U.S. are fully vaccinated against COVID-19, which
constitutes only 66.1% of the total population. This means slightly over half of the U.S.
population is fully protected against COVID-19, which could result in further spread of the
disease and possibly more recorded deaths. Even before the COVID-19 pandemic began,
WHO named vaccine hesitancy, which is the reluctance or refusal to vaccinate despite the
availability of vaccines, as one of the top ten threats to global health (WHO, 2019). Increased
vaccine hesitancy leads to increased disease burden with diseases that could otherwise be
limited or eradicated in the population. There are numerous factors that contribute to vaccine
hesitancy, and they vary depending on the patient population, geographical location, religious
and ethical beliefs, and overall health status of the individual. The American Academy of Family
Physicians (2021) has identified four major reasons for COVID-19 vaccine hesitancy: (a) safety
and efficacy concerns, (b) preference for physiological immunity, (c) distrust in government and
health organizations, and (d) perceived infringement on autonomy and personal freedom.
Interventions are needed to combat this vaccine hesitancy and encourage individuals to get
vaccinated. Therefore, the clinical problem of interest was decreasing vaccine hesitancy and
increasing uptake of the COVID-19 vaccine in the outpatient family medicine setting.
Data Supporting Need for the Project
Global, National, Regional, and State Data
According to the current literature, there were many different methods for addressing
vaccine hesitancy and uptake in the family medicine setting. Kaufman et al. (2018) reported
that face-to-face interventions between healthcare providers (HCPs) and parents of children due
for immunizations that focus on information and education result in improved attitudes, beliefs,
and knowledge about vaccination, and increased not only the intent to vaccinate, but also the
2

vaccination status of the child. As a nurse practitioner (NP), having a purposeful discussion with
children and their parents aimed at educating and informing, while at the same time addressing
questions and concerns, is beneficial for the holistic health of the patient. Patient reminder and
recall interventions used in the primary care setting have also been shown to increase
immunization rates in both children and adults (Khanh-Dao Le, 2020). Reminders are
implemented in many different forms, including telephone calls, text messages, letters,
postcards, or a combination of them, which are created by clinic staff and distributed to the
patients to remind them of their eligibility and need for the vaccine. The National Institute for
Health and Care Excellence (NICE) (2018) recommended that HCPs be educated about the
safety and efficacy of vaccinations so that they are better prepared to teach their clients about
the vaccine, including details such as the risks, benefits, adverse effects, ingredients, and longterm effects. As NPs, it is crucial to be educated about the most current and accurate
vaccination information so they can prepare and empower their patients to make the best
decisions regarding their health, specifically their preventative health. In addition, NPs should
be equipped with the skills and resources to manage vaccine uncertainty in their clients, as well
as promote the acceptance of different vaccines, which can lead to decreased vaccine
hesitancy and increased vaccine uptake in the family medicine setting.
Clinical Agency Data
According to key stakeholders, the clinical site, a family care clinic in northeastern
Indiana, was experiencing frequent COVID-19 vaccine hesitancy and low uptake of the vaccine
among their patient population. The reasons for this hesitancy and low uptake had not been
explored and created a need for inquiry. Those patients who were hesitant about receiving the
vaccination needed to be evaluated for their reasons, thoughts, and concerns so they can be
properly addressed. In addition, the key stakeholders desired successful and cost-effective
interventions be implemented within the clinic to improve uptake of the COVID-19 vaccination.

3

This would increase the safety and overall health of the patients seeking care in the family
practice clinic by protecting them from COVID-19 infection.
Purpose of the Evidence-Based Practice Project
Purpose Statement and PICOT Question
The purpose of the evidence-based practice (EBP) project was to address vaccine
hesitancy and uptake of the COVID-19 vaccine to slow the spread of the virus and decrease the
number of people getting infected, becoming ill, and dying. Decreasing hesitancy and
increasing uptake of the COVID-19 vaccine may help bring an end to one of the worst
pandemics the world has ever seen. The EBP project addressed the following PICOT question:
“For adults 18 years of age and older in a family care setting, does a multimodal intervention,
compared to no intervention (standard of care), decrease hesitancy and increase uptake of the
COVID-19 vaccine over a 10-week time period?”
EBP Project Description
The EBP project took place at a primary care clinic focused on treating patients of all
ages in rural, northeastern Indiana. The project site facilitator was a doctorally prepared
certified NP who served as the liaison between the Doctor of Nursing practice (DNP) student
and the key stakeholders at the clinic. The population of interest for the EBP project was adults,
18 years of age and older, who sought care in the family medicine setting. Participants were
randomly selected from a convenience sample of patients who visited the clinic for routine
health examinations, chronic conditions management appointments, or acute care visits during
the 10-week implementation period. Chart reviews were conducted to assess the current
vaccination status of the patients who had recently visited the clinic and a baseline vaccination
status for participants was documented. The intervention that was implemented to decrease
hesitancy and increase uptake of the COVID-19 vaccine was multimodal. The HCPs within the
clinic received a short, educational session about the COVID-19 vaccine, learned how to best
manage vaccine hesitancy among their patients, and acquired different ways to increase
4

vaccine uptake to improve the health of their patients. Written materials, in the form of a
brochure, were distributed to patients during their visit to the clinic. This resource contained
information about the COVID-19 vaccine, such as its risks, benefits, adverse effects, long-term
effects, current recommendations, and resources available for further inquiry. A patient
reminder, in the form of a business card, was handed to patients during check-in to the clinic,
which served as a reminder to obtain the COVID-19 vaccine, as well as provided details about
how and where to obtain it. To determine the success of the multimodal intervention, the
outcome of interest was uptake of the COVID-19 vaccine. This was measured by change in
vaccination status, determined by chart reviews and/or contacting patients to inquire their
vaccination status. The proposed intervention was implemented over 10 weeks during Fall
2021.
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CHAPTER 2
EBP MODEL AND REVIEW OF LITERATURE
Evidence-based Practice Model
The COVID-19 pandemic is one of the worst health crises the world has ever seen, and
measures must be taken to decrease the spread of the virus and reduce the number of sick and
dying patients. It is the duty of NPs in the family care setting to encourage their patients’
acceptance of preventative health services to improve and promote their overall health.
Interventions are needed to assist HCPs to decrease vaccine hesitancy and increase uptake of
the COVID-19 vaccine in the family care setting. The purpose of the EBP project was to
decrease vaccine hesitancy and increase uptake of the COVID-19 vaccine in the family care
setting. This chapter about the project reviews the EBP model used to guide the entire process,
the extensive literature search performed by the DNP student, a synthesis of the resulting
evidence, and the proposed best practice recommendations for interventions to decrease
vaccine hesitancy and increase uptake of the COVID-19 vaccine in the family care setting.
Overview of EBP Model
The Iowa Model Revised: Evidence-Based Practice to Promote Excellence in Healthcare
(Titler et al., 1994), also known simply as the Iowa Model, was chosen to guide the EBP project.
The model was originally created in the early 1990’s by nursing staff at the University of Iowa
Hospitals and Clinics as a framework for incorporating nursing research into clinical practice
(Titler et al., 1994). The model has been used in a variety of settings in countries all over the
world to improve quality of care being provided to patients. The Iowa Model Collaborative was
created in 2012 to modify the original EBP model as needed to keep it current and applicable to
the ever-changing, modern healthcare system (Iowa Model Collaborative, 2017). The model
underwent a major revision and validation process in 2017 and the result was the Iowa Model-
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Revised, which is the present EBP framework utilized in this EBP project (Iowa Model
Collaborative, 2017).
The Iowa Model-Revised consists of seven sequential steps, with an additional three
critical decision points and corresponding feedback loops to allow for adjustments and
reevaluation as needed throughout the EBP process. Step one is identifying triggering issues
and opportunities, which can be a result of clinical or patient identified issues, organization,
state or national initiatives, new data or evidence, accrediting agency requirements or
regulations, and philosophy of care (Iowa Model Collaborative, 2017). The EBP process begins
by identifying current practices or problems within the healthcare setting that need to be
improved. Step two is formally stating the clinical question or purpose of the EBP project, which
is crucial for keeping the project focused, with the end goal clearly in sight (Iowa Model
Collaborative, 2017). This is commonly referred to as the PICOT question, which determines
the population of interest (P), intervention of interest (I), comparison of interest (C), outcome of
interest (O), and time frame for the project (T). Next, the first critical decision point asks, “Is this
topic a priority?” (Iowa Model Collaborative, 2017). Ensuring the EBP project is important to key
stakeholders, such as the healthcare organization, HCPs, staff members, and patients improves
the probability that the project receives the resources that it needs to be successful, such as
funding and equipment. If the topic is not deemed a priority, a feedback loop leads the EBP
process back to step one and a different issue or opportunity should be chosen; if the topic is
deemed a priority, then the process proceeds to the next step.
Step three is formation of the team, which consists of key stakeholders in the project,
who will work together to design, implement, and evaluate the EBP project (Iowa Model
Collaborative, 2017). All aspects of the project should involve key stakeholders, but every
member need not be involved in every step along the way. Step four is assembling, appraising,
and synthesizing the body of evidence, which consists of conducting a systematic literature
review and evaluating the evidence for quality, quantity, consistency, and risk (Iowa Model
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Collaborative, 2017). Knowledge about how to search for and appraise different types of
evidence is needed to create conclusions regarding the proposed practice change. This leads
to the second critical decision point, which evaluates whether there is sufficient evidence to
support the project (Iowa Model Collaborative, 2017). If the systematic literature search
revealed insufficient evidence supporting the proposed practice change, then a feedback loop
directs the process away from the EBP project and towards conducting research to add to the
existing body of knowledge. However, if it is concluded that there is sufficient evidence to
support the proposed practice change, then the EBP project process proceeds forward.
Step five is designing and piloting the practice change, which consists of engaging
patients and verifying preferences, considering resources, constraints, and approval, developing
a localized protocol, creating an evaluation plan, collecting baseline data, developing an
implementation plan, preparing clinicians and materials, promoting adoption, and collecting and
reporting post-pilot data (Iowa Model Collaborative, 2017). Next comes the third and final
critical decision point, which asks “Is the change appropriate for adoption in practice?” (Iowa
Model Collaborative, 2017). The answer to this question will stem from the evaluation of the
project design and piloting of the practice change. If the implementation was effective and the
results are consistent with the evidence found in the literature, the project may proceed to the
next step. If this is not the case, a feedback loop allows for project redesign and another pilot
implementation will need to occur. Step six is integrating and sustaining the practice change,
which involves identifying and engaging key personnel, hardwiring change into the system,
monitoring key indicators through quality improvement, and reinfusing the change as needed
(Iowa Model Collaborative, 2017). The key stakeholders, in addition to staff members and
patients, will need to continuous reminders, encouragement and support to continue with the
new practice change until it becomes the everyday, standard of care. The seventh and final
step of the Iowa Model is disseminating the results, which means spreading the results of the
practice change to other organizations, practitioners, and patients (Iowa Model Collaborative,
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2017). This step is key in professional development, improving best practice and improving
overall quality of care provided to patients.
The Iowa Model-Revised (Titler et al., 1994) is a practical, effective multi-step change
process that acted as a guide for the EBP project. This EBP model was chosen due to it being
easy to use, highly applicable in the clinical setting, and successful in changing current practice
to best practice. The authors of the EBP model clearly described each step, providing details
about tasks to complete, questions to ask, and important factors to consider. This clarity allows
the user to address each step thoroughly before proceeding to the next step, which is important
when creating an EBP project that is well defined, comprehensive and strong. The EBP model
also allows for smooth progression through the multi-step change process after successful
completion of the previous steps. This clearly delineated path through the process keeps the
user on track towards the end goal of implementing best practice and improving quality of care.
One of the most beneficial and advantageous modifications made to the Iowa Model-Revised
(Titler et al., 1994) is the addition of the critical decision points and feedback loops to the
change process. The critical decision points allow the user to evaluate the current state of the
EBP project at three different times during the process. This evaluation ensures the project is
strong enough to complete the entire EBP process and consequently result in successful
practice change. In addition, the feedback loops allow for modifications and revisions to be
made to the project at different steps in the process, including at the clinical question, literature
search, and project design. These feedback loops allow the user to make changes to the
project while still being able to continue along the change process, without having to start over
from step one.
Literature Search
Sources Examined for Relevant Evidence
An exhaustive literature search was conducted using several different electronic
databases, including Joanna Briggs Institute (JBI), Cochrane Library, Turning Research Into
9

Practice (TRIP) Medical Database, Cumulative Index to Nursing and Allied Health Literature
(CINAHL), and MEDLINE with full text via EBSCO. Initial keywords were extracted from the
PICOT question and included variations of "improving," "vaccination," "decreasing," "hesitancy,"
"COVID-19," and "interventions." Inclusion criteria included the date range 2018-2021, English
language, and peer-reviewed articles. There were no restrictions for population age or
vaccination type, thus articles regarding infants, children, adolescents, and adults receiving any
type of vaccination, such as influenza, human papillomavirus, and pneumococcal, were included
in the literature review. Additional inclusion criteria included interventions that were used to
decrease vaccine hesitancy and increase immunization uptake. Exclusion criteria included
studies that did not involve interventions to decrease vaccine hesitancy or increase
immunization uptake. Low-level evidence, such as editorials or expert opinions, was also
excluded. Citation chasing of studies from reference lists revealed no new relevant studies
different from those found in the database searches. Duplicate studies that appeared in multiple
database searches were eliminated. After altering the search criteria based on observations
and advice from the Research Services Librarian and reviewing the resulting evidence in each
database, the best searches were established (Table 2.1). These final search strings involved
combinations of the following keywords and truncations: immunization OR vaccination OR
vaccin* AND increas* OR uptake OR improv* AND interven* AND family practice OR family
medicine OR primary care OR primary healthcare. A total of 318 pieces of evidence were
screened during the literature searches and of those, 24 pieces were retrieved and assessed for
eligibility. Publications that contained irrelevant interventions or were low level of evidence were
excluded, leaving a total of 11 pieces of evidence included in the systematic review (Figure 2.1).
In JBI, the initial search began simple and straightforward, using the keywords
“improving” AND “vaccination” and a date range limiter since 2018. The search yielded 31
results, with two relevant pieces of evidence, which was a good starting point. Several other
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Table 2.1
Literature Search Grid

Database/
Resource
Searched

Keywords/Phrases Used

Limiters
Used

Number of
Results
from
Search

Number of
Pieces of
Evidence
Deemed
Relevant
to Project

Number of
Pieces of
Evidence
Selected
for Use in
Paper

JBI

Immunization OR
vaccination OR vaccine
AND increase OR uptake

2018current

53

4

2

Cochrane

Improve
AND vaccinations
AND interventions

January
2018- June
2021

15

3

3

TRIP

(title: immunization) AND
(uptake OR increas*)

From 2018;
Guidelines

57

5

2

CINAHL

(MM “immunization”) OR
(MM “vaccin*) AND uptake
OR increas* OR improv*
AND “family practice” OR
“family medicine” OR
“primary care” OR “primary
healthcare” OR “primary
health care”

2018-2021;
English
language;
Peerreviewed

89

7

2

MEDLINE

(MM “immunization”) OR
(MM “vaccin*) AND uptake
OR increas* OR improv*
AND “family practice” OR
“family medicine” OR
“primary care” OR “primary
healthcare” OR “primary
health care” AND interven*

2018-2021;
English
language;
Peerreviewed

104

5

2

318

24

11

Total
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Figure 2.1
PRISMA Diagram of Literature Search

Screening

Identification

Identification of Studies via Databases and Registers
Records removed before
screening:
Duplicate records removed
(n = 5)
Records marked as ineligible
by automation tools (n = 0)
Records removed for other
reasons (n = 0)

Records identified from:
JBI (n = 53)
Cochrane Library (n = 15)
TRIP Database (n = 57)
CINAHL (n = 89)
MEDLINE (n = 104)
Total (n = 318)

Records screened
(n = 313)

Records excluded
(n = 289)

Reports sought for retrieval
(n = 24)

Reports not retrieved
(n = 0)

Included

Reports assessed for eligibility
(n = 24)

Reports excluded:
Intervention irrelevant (n = 7)
Low level of evidence (n = 6)

Studies included in review
(n = 11)
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similar searches were conducted using similar keywords, such as “increasing,” and “promoting,”
“uptake,” and “immunization.” It was found that changing the keywords “improving” to “increase”
and “vaccination” to “immunization” resulted in a greater number of relevant pieces of evidence.
The focus of the keywords was then changed to “decreasing,” AND “vaccine,” AND
“hesitancy,” with many attempts made using synonyms for hesitancy, such as reluctance,
uncertainty, doubt, and indecision. These searches yielded fewer overall results, most of which
were duplicates from previous, more successful searches. Several searches were conducted
using the keyword “COVID-19” in attempts to get more specific results, however there were few
to no results in each search, none of which were relevant to the project. In the end, the final,
most successful search in JBI consisted of a variation of the original search, with an
improvement from the guidance of the Research Services Librarian. The search consisted of
the keywords “immunization” OR “vaccination” OR “vaccine” AND “increase” OR “uptake,” with
the date range limiter of since 2018. This search yielded 53 results, 4 of which were relevant,
and 2 that were included in the final review (Khanh-Dao Le, 2021; Sivapuram, 2021). Using
similar keywords and Boolean operators increased the number of results, including relevant
pieces, and therefore resulted in a more successful search.
Building on the knowledge of keywords and results learned from the JBI searches, the
search in Cochrane Library began using the keywords “improve” AND “vaccinations” AND
“interventions” and a date range limiter of 2018-2021. This resulted in 15 Cochrane Reviews, 3
of which were deemed relevant. The search was expanded to include synonyms and appeared
as “immunization” OR “vaccination” OR “vaccine” AND “increase” OR “improve” OR “uptake.”
This resulted in 125 Cochrane Reviews, which was a great increase in the number of results,
but no new relevant pieces of evidence other than the original 3 pieces. The keyword
“intervention” was then added into the search to attempt to streamline the results. This search
resulted in 81 Cochrane Reviews, but still only had the original 3 relevant pieces of evidence
and no additional ones. Similar to the search strategy in JBI, the focus of the keywords was
13

changed to “decreasing,” AND “vaccine,” AND “hesitancy.” However, these searches were
unsuccessful and yielded, at best, one Cochrane Review. Several searches were conducted
using the keywords “COVID-19” AND “vaccine,” and resulted in very few pieces of evidence. In
addition, the pieces yielded were protocols or clinical trials, which have not been published or
peer-reviewed yet, and thus, were categorized as low-level pieces of evidence. These results
were not surprising as the COVID-19 virus and pandemic are still too new in nature to have
many proven clinical studies published. The best, most successful search in Cochrane Library
ended up being the original search, which consisted of the keywords “improve” AND
“vaccinations” AND “interventions” with a date range limiter of 2018-2021. This search resulted
in 15 Cochrane Reviews, 3 of which were deemed relevant, and all of which were used in the
final review (Jacobson Vann et al., 2018; Kaufman et al., 2018; Thomas & Lorenzetti, 2018).
The search in the database TRIP proved to be the most challenging, but after numerous
modifications to the search methods and assistance from the Research Services Librarian,
ended in a successful literature review. The original search began simple, with the key phrase
“increasing vaccination rates” and the limiters of date range since 2018 and Guidelines. This
search yielded 705 results, which was far too many to examine thoroughly. Initial assessment
of the first page of results showed one relevant guideline. The search was altered in attempts to
narrow the results, using the keywords “COVID” AND “vaccine” AND “uptake” and the same
limiters as the initial search. This search yielded 30 results, which was much more
manageable, with one relevant guideline, although different from that of the initial search.
Numerous other searches were conducted using similar keywords, truncations, and Boolean
operators, however none yielded more than one relevant piece of evidence. The search was
then modified, with assistance from the Research Services Librarian, to include
(title:immunization) AND (uptake OR increas*), which streamlined articles with the keyword
“immunization” in the title. This search strategy allowed for a more focused article return. The
limiters of date range since 2018 and Guidelines was applied and the search yielded 57 results,
14

5 of which were relevant, and 2 of which were included in the final literature review (Canadian
Paediatric Society, 2018; NICE, 2018).
The initial search in CINAHL was more sophisticated than the other databases and
consisted of “improv*” OR “increase*” AND “vaccinat*” AND “COVID-19,” with the limiters of
date range 2018-2021, English language, and peer reviewed. This search yielded 111 results,
with numerous potentially relevant pieces of evidence. The search was redesigned to procure
more focused, relevant studies and consisted of the keywords “vaccination” OR “immunization”
OR “vaccines” AND “interventions” OR “strategies” OR “best practices” AND “increase” OR
“improve” OR “enhance” with the same limiters as the initial search. The outcome was 973
pieces of evidence, which were far too many to review. Many other similar searches were
conducted, using different keywords, truncations, and Boolean operators, attempting to achieve
a more manageable number of results, while maintaining the high level of relevance. These
searches proved to yield too many results to review, with only a portion of them being relevant.
The use of a CINAHL major heading, which finds articles with that particular keyword in the title
of the article, proved to be effective at streamlining relevant pieces of evidence. In addition,
adding keywords relating to the setting, such as family medicine or primary care, continued to
streamline the results and provided more relevant pieces of evidence. The subsequent search
proved to be the most successful and consisted of (MM “immunization”) OR (MM “vaccin*) AND
“uptake” OR “increas*” OR “improv*” AND “family practice” OR “family medicine” OR “primary
care” OR “primary healthcare” OR “primary health care” with the limiters of date range 2018 to
2021, English language, and peer reviewed. This search yielded 89 results, with 7 of them
being relevant to the project, and 2 of them being included in the final literature review (Ho et al.,
2019; Reno et al., 2018).
The same search criteria for CINAHL were utilized in MEDLINE due to the similar nature
of the electronic databases. However, the initial search yielded 292 results, which was too
many to review. To narrow the results, the keyword “interven*” was added to the search.
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Therefore, the final search, which proved to be the best, was as follows: (MM “immunization”)
OR (MM “vaccin*) AND “uptake” OR “increas*” OR “improv*” AND “family practice” OR “family
medicine” OR “primary care” OR “primary healthcare” OR “primary health care” AND “interven*”
with the limiters of date range 2018 to 2021, English language, and peer reviewed. This search
resulted in 104 pieces of evidence, 5 of which were relevant to the project and 2 of which were
selected for the final literature review (Jaca et al., 2018; Sanftenberg et al., 2019).
Levels of Evidence
The pieces of evidence selected for use in the literature review were leveled using the
hierarchy of evidence according to Melnyk and Fineout-Overholt (2019). This hierarchy of
evidence is assembled according to types of research studies and the overall reliability of the
answers to specific clinical questions. Evidence at the top of the hierarchy exhibit lower risk of
bias and are more generalizable to different populations (Melnyk & Fineout-Overholt, 2019). In
addition, findings from this evidence are more likely to represent the real-life situations and
therefore clinicians can use the interventions in the study and have greater confidence that they
will achieve the same outcomes with their patients. At the same time, evidence at the bottom of
the hierarchy exhibit higher risk of bias, are less generalizable to different populations, and are
used by clinicians with less confidence (Melnyk & Fineout-Overholt, 2019). The EBP project
literature review produced 11 relevant pieces of evidence, all of which were high levels of
evidence (Table 2.2). Nine of the pieces of evidence were categorized as Level I, consisting of
two evidence summaries (Khanh-Dao Le, 2021; Sivapuram, 2021), five systematic reviews
(Jacobson Vann et al, 2018; Kaufman et al., 2018; Thomas & Lorenzetti, 2018; Jaca et al.,
2018; Sanftenberg et al., 2019), and two clinical practice guidelines (CPGs) (Canadian
Paediatric Society, 2018; NICE, 2018). The remaining two pieces of evidence were categorized
as Level II and were both randomized controlled trials (RCTs) (Ho et al., 2019; Reno et al.,
2018).
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Table 2.2
Summary of Evidence
Author/Year

Database

Level of
Evidence/Type

Quality/Tool

Khanh-Dao Le (2021)

JBI

I/Summary

Strong/CASP

Sivapuram (2021)

JBI

I/Summary

Strong/CASP

Kaufman et al. (2018)

Cochrane

I/Systematic Review

Strong/CASP

Thomas & Lorenzetti (2018) Cochrane

I/Systematic Review

Strong/CASP

Jacobson Vann et al. (2018) Cochrane

I/Systematic Review

Strong/CASP

Canadian Paediatric
Society (2018)

TRIP

I/CPG

Strong/AGREE II

NICE (2018)

TRIP

I/CPG

Strong/AGREE II

Jaca et al. (2018)

MEDLINE

I/Systematic Review

Strong/CASP

Sanftenberg et al. (2019)

MEDLINE

I/Systematic Review

Strong/CASP

Reno et al. (2018)

CINAHL

II/RCT

Good/CASP

Ho et al. (2019)

CINAHL

II/RCT

Good/CASP

17

Analysis and Appraisal of Relevant Evidence
The two tools utilized to appraise the selected pieces of evidence were the Critical
Appraisal Skills Programme (CASP) (CASP, 2019a; CASP, 2019b) tool and the Appraisal of
Guidelines for Research and Evaluation (AGREE) II (Brouwers et al., 2010). The CASP tool
(CASP, 2019a; CASP, 2019b) was used to appraise majority of the pieces of evidence,
including the two evidence summaries (Khanh-Dao Le, 2021; Sivapuram, 2021), the five
systematic reviews (Jacobson Vann et al, 2018; Kaufman et al., 2018; Thomas & Lorenzetti,
2018; Jaca et al., 2018; Sanftenberg et al., 2019), and the two RCTs (Ho et al., 2019; Reno et
al., 2018). The AGREE II (Brouwers et al., 2010) was used to appraise the remaining two
pieces of evidence, which were CPGs (Canadian Paediatric Society, 2018; NICE, 2018). The
two evidence summaries, five systematic reviews, and two CPGs were appraised to be strong
quality, while the two RCTs were appraised to be good quality (Table 2.2).
The CASP tool (CASP, 2019a; CASP, 2019b) was chosen due to its applicability to the
types of studies that needed to be appraised, as well as its thoroughness and ease of use.
There was a specific CASP form for systematic reviews (CASP, 2019b), which was also used
for the evidence summaries, and a separate form for the RCTs (CASP, 2019a). The CASP tool
(CASP, 2019a; CASP, 2019b) asks specific main questions that assess different aspects of the
study, which allows the user to comprehensively appraise the article. The tool also lists
additional questions under each main question to stimulate the user to consider more specific
details. The tool offers answer choices of “yes,” “no,” or “can’t tell” in addition to word boxes
that allow for further explanation and comments. The forms were thorough enough to appraise
the quality of the evidence, yet still brief and manageable. The AGREE II (Brouwers et al.,
2010) was used to appraise the two CPGs, as this tool was created specifically for appraising
this type of publication. The tool is methodical, as it addresses six critical domains of CPGs,
ranging from scope and purpose to clarity of presentation to applicability. There are several
questions within each domain that address specific criteria that should be included in the CPG
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as a whole. Determining which of these criteria are present, missing, or needs improvement
helps the user rate the quality of the CPG. The AGREE II (Brouwers et al., 2010) was user
friendly and comprehensive in its ability to appraise CPGs, which is why it was selected to
appraise the selected pieces of evidence.
Construction of Evidence-based Practice
Synthesis of Critically Appraised Literature
A review of literature was performed to find best practice regarding decreasing hesitancy
and improving uptake of the COVID-19 vaccination. Due to the new nature of the COVID-19
virus and vaccination, the availability of high level, strong evidence was limited. However, the
literature was saturated with evidence about addressing vaccine hesitancy and uptake of other
vaccinations, such as influenza, human papillomavirus, and pneumococcal. Thus, the literature
search primarily focused on interventions, including patient reminders and education, utilized by
HCPs in the primary care setting to decease vaccine hesitancy and increase immunization
uptake (Appendix A).
Patient Reminders: Letters and Postcards
The most prevalent intervention in the literature was written patient reminders, in the
form of letters or postcards mailed to the patients’ house (Canadian Paediatric Society, 2018;
Jaca et al., 2018; Jacobson Vann et al., 2018; Khanh-Dao Le, 2021; NICE, 2018; Sanftenberg
et al., 2019; Thomas & Lorenzetti, 2018). Vaccination reminders mailed to the homes of
patients’ gives them a tangible prompt to obtain the vaccine, call and make an appointment to
receive it, or inquire about it to their HCP during their next appointment at the office. The letter
or postcard can be kept at the patients’ disposal for as long as they feel necessary and may
serve as a constant reminder for vaccination. Thomas and Lorenzetti (2018) found that patients
who received a reminder by letter or postcard were 11% more likely to receive the influenza
immunization compared to those who did not.
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The literature also shows that the message and tone of the reminder is as important as
the physical reminder itself when it comes to decreasing vaccine hesitancy and increasing
uptake of the vaccine (Canadian Paediatric Society, 2018; NICE, 2018; Sivapuram, 2021).
Specific information regarding vaccination should be provided to patients, such as benefits,
risks, contraindications, ingredients, safety, and who is eligible and when (Canadian Paediatric
Society, 2018; NICE, 2018; Sivapuram, 2021). Providing patients with this information allows
them to be better educated, which could cause them to make more informed, advantageous
decisions regarding their health. In addition, the information should be evidence-based,
accurate, consistent, positive, and written in plain language in a manner that can be
comprehended by the audience (Canadian Paediatric Society, 2018; NICE, 2018; Sivapuram,
2021). This information may allow the patient to better comprehend the details of the vaccine,
which could decrease hesitancy in those experiencing it and possibly increase uptake in those
willing to vaccinate.
Patient Reminders: Electronic
Another prevalent intervention in the literature to decrease vaccine hesitancy and
increase uptake was electronic patient reminders, in the form of telephone calls, text messages,
emails, and patient portal or electronic medical record (EMR) messages (Canadian Paediatric
Society, 2018; Jaca et al., 2018; Jacobson Vann et al., 2018; Khanh-Dao Le, 2021; NICE, 2018;
Sanftenberg et al., 2019; Thomas & Lorenzetti, 2018). Similar to the written patient reminders,
these electronic reminders are provided to the patients in order to prompt vaccination.
Messages can be sent to patients who are eligible for vaccination to not only remind them of
their eligibility, but also their lack of current vaccines. These messages may also provide
information regarding frequently asked questions, accessibility, and locations to receive the
vaccine, and possibly even the cost or financial coverage. This information may be helpful to
patients who are experiencing vaccine hesitancy. Jacobson Vann et al. (2018) concluded that
telephone calls, autodialer calls and text messages increased the likelihood of receiving
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immunizations by 28% when compared to no patient reminder or recall interventions.
Automated, electronic messages are not only cost effective but also time efficient for clinics to
reach many patients in a short amount of time.
Education: Patients
The literature revealed that education provided to patients can decrease vaccine
hesitancy and increase uptake of different routine vaccines (Jaca et al., 2018; Kaufman et al.,
2018; NICE, 2018; Reno et al., 2018; Sanftenberg et al., 2019; Thomas & Lorenzetti, 2018).
Jaca et al. (2018) found that patients who received education were 92% more likely to receive
vaccination coverage compared to those who did not. Education can be provided to patients in
a variety of manners, but a face-to-face session with the provider was shown to be the most
effective (Jaca et al., 2018; Kaufman et al., 2018; NICE, 2018; Reno et al., 2018; Thomas &
Lorenzetti, 2018). A personal interaction allows the patient and HCP to have a two-way
discussion about the vaccine and any concerns there may be with receiving, obtaining, or
tolerating it. This conversation may allow for misconceptions to be corrected and questions to
be answered, resulting in increased uptake of the vaccine.
Education: Health Care Providers
Furthermore, education provided to HCPs also improves vaccination rates and reduces
vaccine hesitancy. Sanftenberg et al. (2019) reported that educational or training sessions
given to HCPs regarding the particular vaccine and disease may raise vaccination rates up to
22%. Education and training ensure that HCPs are informed with the most current, relevant and
accurate information regarding vaccines, as well as methods of properly addressing vaccine
hesitancy with patients (Jaca et al., 2018; NICE, 2018; Reno et al., 2018; Sanftenberg et al.,
2019). It is crucial that HCPs not only be properly informed of the details of vaccines, but also
on how to properly have compassionate, informative vaccination-related discussions with
patients. Educating patients and HCPs can result in decreased vaccine hesitancy and
increased uptake of vaccinations by patients.
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Recommendation for Best Practice
Based on the synthesis of the literature, the best practice to address the clinical problem
of decreasing vaccine hesitancy and increasing uptake of the COVID-19 vaccine was a
multimodal intervention. The intervention consisted of three components: a) an educational
session for HCPs to ensure they were up to date on current COVID-19 vaccine details and felt
prepared for empathetic, informative discussions with their patients, especially those who were
vaccine hesitant; b) reminder cards which were given to patients to serve as a reminder to
obtain the COVID-19 vaccine and inform them of the where and how to do so; and c) brochures,
which contained information about the current COVID-19 vaccine statistics, recommendations
for reception, benefits, side effects, contraindications, frequently asked questions, and other
pertinent information regarding the vaccine, given to patients while visiting the clinic.
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CHAPTER 3
IMPLEMENTATION OF PRACTICE CHANGE
The DNP plays a critical role in implementing clinical practice change throughout the
healthcare system. DNPs are qualified and experienced to recognize a need for change in
practice to improve patient health outcomes. A search of the literature is conducted to find
evidence of best practice, the results are critically appraised, and the best intervention is chosen
to implement. The DNP is then responsible for integrating the new practice change into
everyday workflow by identifying and recruiting key stakeholders, acquiring necessary
resources, preparing the environment, creating an implementation and evaluation plan,
monitoring the course of the project, modifying the practice change as needed, and assessing
patient health outcomes. The purpose of implementing EBP change is to improve quality of
care and health outcomes for all patients.
The purpose of the EBP project was to decrease hesitancy and increase uptake of the
COVID-19 vaccine in the family care setting. After a thorough review of the literature, it was
concluded that the best practice for this specific clinical setting was a multimodal intervention of
staff education, informational brochures, and written reminders. Staff at the clinic, including the
physician, nurse practitioner, nurses, and medical assistants received a 30-minute educational
session, in the form of a PowerPoint presentation, led by the DNP student (Appendix B). The
purpose of the session was to educate the staff with the most up-to-date information regarding
the COVID-19 vaccine and its recommendations, while helping them to feel prepared to advise
vaccine hesitant patients effectively and empathetically. Informational brochures were given to
patients upon check-in to the clinic with the intent of educating and encouraging vaccinefocused conversations with their HCPs. The brochures (Appendix C) contained information
about the current COVID-19 vaccine statistics, recommendations for reception, benefits, side
effects, contraindications, frequently asked questions, and other pertinent information regarding
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the vaccine. A reminder card (Appendix D) was also handed to patients upon check-in to the
clinic in which they could take home with them. The purpose of the card was to serve as a
reminder to obtain the COVID-19 vaccine, as well as provide details regarding the price of the
vaccine, nearby locations to receive the vaccine, and information on how to schedule an
appointment. The outcome of interest of the EBP project was the uptake of the COVID-19
vaccine and was measured through post-intervention chart reviews and personal phone calls to
assess vaccination status.
Participants and Setting
All staff members at the clinic, which included one physician, one NP, three nurses, and
three medical assistants, participated in the project and each had their own specific roles in the
implementation. The physician has been practicing medicine for 20 years, approximately 15 of
which have been at the current clinic. The NP has been a nurse practitioner for 4 years, all of
which have been at the current clinic. The staff members at the clinic attended the educational
session, led by the DNP student, where they learned the details of the project, received the
most up-to-date COVID-19 vaccine information, and heard strategies to manage vaccine
hesitancy. The physician and NP were responsible for answering questions from their patients
regarding the COVID-19 vaccine and addressing vaccine hesitancy when necessary. The
medical assistants handed out brochures and reminder cards, created by the DNP student, to
patients as they checked into the clinic. The nurses, medical assistants, and the DNP student
were tasked with documenting the COVID-19 vaccination status in the EMR during the rooming
process and follow-up period.
The patient population of interest for the project was patients 18 years and older who
had not received the COVID-19 vaccine and visited the clinic during the 10-week
implementation period. The only patients who were ineligible to participate in the study included
those who were under the age of 18 years, those who had already received at least one dose of
the COVID-19 vaccine, those who were allergic to any of the ingredients in the vaccine, and
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those who had previously had an allergic reaction to another vaccine. There were no
restrictions regarding gender, ethnicity, socioeconomic status, medical conditions, or current
health status. A list of patients with scheduled appointments per day was available in the EMR
and at the conclusion of the day the list was filtered by those who kept their appointment. This
list of patients was used as the list of eligible participants during the implementation period.
The setting for the EBP project was a community owned, nonprofit clinic, which served
approximately 2,000 patients by two primary care providers: (a) a physician, and (b) a family
NP. The clinic was a part of a larger healthcare system, which was also community owned and
nonprofit, and had 36 healthcare facilities spread around Northeastern Indiana.
Pre-Intervention Group Characteristics
For those patients who were selected to be participants of the project, demographic
information was collected: (a) gender at birth, which included male or female, (b) age in years,
and (c) race, which was categorized as White, Black, Hispanic, Asian, or other (Appendix E).
Baseline COVID-19 vaccination status was also collected for each patient selected.
Intervention
Through the review of literature, the DNP student found many different successful
interventions to decrease vaccine hesitancy and increase uptake. Thus, a multimodal
intervention, consisting of provider education (Jaca et al., 2018; NICE, 2018; Reno et al., 2018;
Sanftenberg et al., 2019), informational brochures (Jaca et al., 2018; Kaufman et al., 2018;
NICE, 2018; Reno et al., 2018; Sanftenberg et al., 2019; Thomas & Lorenzetti, 2018), and
patient reminders (Canadian Paediatric Society, 2018; Jaca et al., 2018; Jacobson Vann et al.,
2018; Khanh-Dao Le, 2021; NICE, 2018; Sanftenberg et al., 2019; Thomas & Lorenzetti, 2018)
were created to have the greatest positive impact on vaccine hesitancy and uptake during the
implementation period.
Initially, a 30-minute educational session, led by the DNP student, was provided to all
staff members at the clinic, including the physician, NP, nurses, and medical assistants. The
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session occurred the morning of Tuesday, October 19, 2021, before the clinic opened and
patients arrived, so all staff members could be present. A PowerPoint presentation (Appendix
B) was created by the DNP student and copies of the slides were printed and given to staff
members. The purpose of the session was to ensure staff members were well versed in the
most current information regarding the COVID-19 vaccine, including current recommendations,
safety, efficacy, benefits, side effects, and contraindications. In addition, the educational
session provided staff members with knowledge of the concept of vaccine hesitancy and
effective and compassionate strategies of working with patients who were vaccine hesitant. It
was crucial that staff members felt informed on the current facts and recommendations of the
COVID-19 vaccine, as well as felt prepared to answer questions and concerns of patients who
presented to the clinic. This ensured the COVID-19 vaccine was being discussed regularly,
openly, and accurately, with the intention of decreasing vaccine hesitancy and increasing
uptake of the vaccine.
The second arm of the intervention was the distribution of informational brochures to
patients. Designed by the DNP student, the brochures (Appendix C) contained information
about current COVID-19 vaccine statistics, recommendations for reception, benefits, side
effects, contraindications, frequently asked questions, and other pertinent information regarding
the vaccine. The information was in accord with the most recent and accurate national data and
was approved by the DNP student’s project advisor and staff at the clinic prior to publication and
distribution. Brochures were printed at a local office supply shop and the DNP student funded
the total printing costs. The brochures were handed to patients, by the medical assistants, upon
check-in to the clinic for their scheduled appointments. The information was potentially
reviewed while sitting in the waiting room, while waiting for the provider in the exam room, or
took home to be further processed. The intent of the brochures was to educate patients about
the COVID-19 vaccine, encourage vaccine-focused conversations with their HCPs, and
ultimately motivate patients to receive the COVID-19 vaccine. To assure that information on the
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brochures was up-to-date, the DNP student regularly reviewed them. For example, the
minimum age of vaccine receipt was lowered from 12 years of age to 5 years on November 2,
2021 (CDC, 2022, January 5), so the informational brochures were updated, reprinted, and
redistributed once during the implementation period.
The final component of the multimodal intervention was a patient reminder card created
by the DNP student and distributed to patients visiting the clinic during the implementation
period. The reminder card (Appendix D) was handed to patients during check-in for their
appointments with the intent of being taken home to serve as a reminder to obtain the COVID19 vaccine. The reminder card contained information such as the price of the vaccine, nearby
locations to receive the vaccine, and information on how to schedule an appointment. The
information was congruent with the latest national data and was approved by the university
project advisor and staff at the clinic before publication and distribution.
Comparison
As of April 27, 2022, 219,550,028 people in the US are fully vaccinated, representing
66.1% of the population (CDC, 2022 April 27). In Indiana, 3,688,160 people are fully
vaccinated, representing 55.6% of the state population (CDC, 2022 April 27). These statistics
reveal that the state of Indiana, which is where the clinic resides, is almost 11% below the
national percentage of people who are fully vaccinated against COVID-19. This indicates a
need for interventions in the clinical setting to decrease vaccine hesitancy and increase uptake
of the COVID-19 vaccine. Doing so will protect the patients from contracting the COVID-19
virus and ultimately improve their overall health.
The outcome of the EBP project was uptake of the COVID-19 vaccine in the family care
setting. The statistical question of interest was “What is the change in COVID-19 vaccination
rate after exposure to the intervention?” A statistical test of frequency was calculated on the
data to measure the change and was expressed as a percentage. The data collected during
implementation was divided into two categories: “yes” or “no.” These data are considered
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nominal level of measurement, due to the presence of categories that are unordered or nondirectional.
Outcomes
The outcome of interest in the EBP project was uptake of the COVID-19 vaccine. Prior
to this EBP project, the medical assistants and nurses in the clinic had been asking patients
about their COVID-19 vaccination status during the rooming and preparation process for the
patients’ appointment. If the patient had received the COVID-19 vaccine, the dose(s)
information, such as the manufacturer and date received, was added to the patient’s chart under
the vaccination history. If the patient had received the COVID-19 vaccine but did not have his
or her card to obtain the details, a simple “COVID vaccine: yes” was written under the intake
note. If the patient had not received the COVID-19 vaccine, “COVID vaccine: no” was written
under the intake note. Using chart audits, the DNP student collected this information on all
randomly selected participants comprising the project sample.
The sample was obtained from daily schedules of kept appointments for each healthcare
provider, which were printed off at the end of each week. Patients under the age of 18 years
were excluded from the sample and crossed off the list. The remaining patients on the list of
appointments seen in the clinic were then numbered sequentially. The Random Number
Generator application (Dean, 2022) was utilized to select 15 patients from the list of each of the
10 weeks during the implementation period. Demographic data, including patient age, gender,
race and medical record number were recorded. COVID-19 vaccination status was collected
and recorded on each of these selected participants using chart reviews in the EMR (Appendix
E). Those participants who had received at least one of the COVID-19 vaccines were excluded
from the sample, and those who had not received any doses were included and comprised the
EBP project sample.
Post-intervention COVID-19 vaccination status was obtained through a combination of
chart reviews and personal outreach to the patients. Initially, chart reviews were preformed 4
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weeks after the day of the intervention, which was the date of their appointment at the clinic, to
assess whether the patient has received the COVID-19 vaccine. The time frame of 4 weeks
was chosen to allow patients to make an informed decision about whether to receive the
COVID-19 vaccine and then enable them to physically obtain the vaccine if chosen to do so.
This chart review was used to determine whether the COVID-19 vaccine information had been
documented in the vaccination history section of the patient’s chart or if the patient had returned
to the clinic for another appointment. If there was no recorded COVID-19 vaccine information in
the patients’ chart, the DNP student reached out to the patient via telephone call to inquire
whether the patient had received a dose of the vaccine. This information was recorded on a
data collection form created by the DNP student (Appendix F). In addition, if patients had
received the COVID-19 vaccine since the intervention, the information was added to the
patients chart to accurately reflect their vaccine history. The post-intervention COVID-19
vaccination rate was calculated to reflect the change in vaccination status of the participants
and thus evaluate the effectiveness of the intervention.
Time
The PowerPoint used in the provider educational session (Appendix B), the informational
brochures (Appendix C), and the patient reminder cards (Appendix D) were created prior to the
10-week implementation period. The DNP students’ advisor at Valparaiso University and the
project site facilitator at the clinic approved the materials prior to publication and distribution.
The first arm of the intervention, the 30-minute educational session with staff members,
occurred on the morning of Tuesday, October 19, 2021, before the clinic opened. The other two
arms of the intervention, the distribution of informational brochures and patient reminder cards,
began on Monday, October 25, 2021, marking the beginning of the implementation period. The
intervention was executed for 10 consecutive weeks, ending on Friday, December 31, 2021.
Post-intervention COVID-19 vaccination status was evaluated 4-weeks after the participant was
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exposed to the intervention, beginning on Monday, November 22, 2021, and ending on Friday,
January 28, 2022.
Protection of Human Subjects
The DNP student completed research ethics training through the Collaborative
Institutional Training Initiative (CITI) program on April 9, 2021 (Appendix G). An application for
Institutional Review Boards (IRB) approval was submitted through the IRB Board at Valparaiso
University on August 7, 2021, and they indicated “IRB Approval Not Required.” The abstract
and details of the EBP project were also submitted to the IRB Board associated with the clinical
site and the project was deemed exempt from needing formal IRB approval. All these steps
were completed prior to the implementation and evaluation of the EBP project to ensure patient
safety and ethical conduct.
Patient identifiers were kept anonymous by using a double coding system known only to
the DNP student (Appendix H). This information was kept in separate locations in secure files.
The data from the EBP project were secured on the DNP student’s laptop, which was locked
using a secure password known only to the DNP student herself.
The implementation of the EBP project was aimed at changing current practice within
the clinic to an evidence-based practice to improve patient outcomes. The multimodal
intervention, which consisted of staff education, informational brochures, and patient reminders,
was implemented to decrease vaccine hesitancy and increase uptake of the COVID-19 vaccine
in the family care setting. Increasing the vaccination rate against COVID-19 will improve patient
outcomes by decreasing number of COVID-19 positive cases, hospitalizations, ICU admissions,
and deaths.

30

CHAPTER 4
FINDINGS
Evidence from the literature showed numerous interventions, such as written and
electronic patient reminders and patient and staff education, to increase uptake of different
vaccines. These findings were used to support the need for and creation of the EBP project,
where a multimodal intervention, consisting of staff education, informational brochures, and
patient reminders, was created to decrease hesitancy and increase uptake of the COVID-19
vaccine. The EBP project was implemented over a 10-week time period in a family care setting
and its effectiveness was evaluated. The findings from this EBP project do not support the use
of a multimodal intervention, in the form of staff education, informational brochures, and patient
reminders, to decrease hesitancy and increase uptake of the COVID-19 vaccine in the family
care setting.
Participants
All staff members at the clinic, including one physician, one NP, three nurses and three
medical assistants, were active participants in the implementation of the EBP project. These
healthcare professionals attended the education session, which was delivered by the DNP
student, where they learned the details of the project, received the most up-to-date COVID-19
vaccine information, and heard strategies to manage vaccine hesitancy. These eight individuals
each had unique and crucial roles in the EBP project, which aimed at decreasing vaccine
hesitancy and increasing uptake of the COVID-19 vaccine in the patients seeking care at the
clinic.
Inclusion criteria for participants in the EBP project consisted of individuals who were 18
years of age and older, had not received the COVID-19 vaccine, and visited the clinic during the
10-week implementation period. Exclusion criteria included those individuals under the age of
18 years, those who had already received at least one dose of the COVID-19 vaccine, those
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who were allergic to any of the ingredients in the vaccine, those who had previously had an
allergic reaction to another vaccine, and those who did not visit the clinic within the 10-week
implementation period. Over the course of project implementation, 15 individuals who met the
inclusion criteria were randomly selected each week during the 10-week period, which resulted
in a 150-person convenience sample. Chart audits were conducted on these selected persons
to assess whether they had received at least one dose of the COVID-19 vaccine. Of the 150
individuals, 96 were vaccinated, constituting 64% of the sample, and 54 were not vaccinated,
making up the remaining 36%. The latter portion of the sample became the sample of
participants utilized in the analysis of the project intervention (Table 4.1).
Of the nonvaccinated participants, 59.3% were female and 40.7% were male, according
to their assigned gender at birth in the EMR. The age of participants ranged from 20 years to
89 years, with the mean age being 51 years (SD = 16.45). The race of participants was
evaluated and 85.2% of the sample identified as white, 1.8% as Black, 7.4% as Hispanic, 0% as
Asian, and 5.6% as Other (Table 4.2). Demographic data of the entire patient population of the
clinic was unattainable, so project data was compared to data of Elkhart County, IN, which is
where the clinic was located. Proportions of participants’ identified race in the EBP project were
comparable to that of demographic data of the surrounding community (United States Census
Bureau, 2021 July 1).
Changes in Outcomes
The EBP project addressed the following PICOT question: “In adults 18 years of age and
older in the family care setting, does a multimodal intervention, compared to no intervention
(standard of care), decrease hesitancy and increase uptake of the COVID-19 vaccine over a 10week time period?” At the 4-week follow-up evaluation, 3 of the 54 participants, constituting
5.6% of the sample, had received a dose of the COVID-19 vaccine after being exposed to the
multimodal intervention (Figure 4.1). Therefore, there was no significant change in the COVID19 vaccination status of the sample, which was the outcome of interest.
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Table 4.1
Baseline Vaccination Status of all Participants

Week #

Vaccinated

Not Vaccinated

1

8

7

2

12

3

3

7

8

4

10

5

5

9

6

6

11

4

7

9

6

8

14

1

9

8

7

10

8

7

Total

96 (64%)

54 (36%)
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Table 4.2
Demographic Characteristics
Characteristic

Total (N=54)

Age M(SD)

51 (SD=16.45)

Gender
Male
Female

22 (40.7%)
32 (59.3%)

Race
White
Black
Hispanic
Asian
Other

46 (85.2%)
1 (1.8%)
4 (7.4)
0 (0%)
3 (5.6%)
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Figure 4.1
Vaccination Status at Week 4

35

Statistical Testing and Significance
The demographic data in this EBP project were a combination of different levels of
measurement. Gender and race are nominal levels of measurement, as there are different
categories but there is no ranking or hierarchal ordering. Age is ratio level of measurement, as
there is an order and rank to the measurements with equal intervals between them and there is
an absolute value of zero. Descriptive statistics were run on the data and measures of
variation, such as minimum, maximum, and range, were calculated on the demographic
category of age, measures of central tendency, such as mean, were calculated on the
demographic category of age, and measures of frequency, such as percent, were calculated on
the demographic category of gender and race. The outcome of this EBP project, COVID-19
vaccination status, was analyzed using the statistical test of frequency and presented as a
percent (Cronk, 2019). The statistical significance of the outcome was determined using the
calculation of relative risk (Cronk, 2019).
Findings
Outcome: COVID-19 Vaccination Rates.
At baseline, none of the participants had received the COVID-19 vaccine, constituting a
0% vaccination rate. These individuals were exposed to the multimodal intervention, consisting
of staff education, informational brochures, and patient reminder cards, in the clinic. The
COVID-19 vaccination status was reevaluated 4-weeks after exposure to the intervention.
There were three participants, constituting 5.6% of the sample, who received the COVID-19
vaccine after implementation of the intervention. Relative risk was calculated and revealed that
there was no statistically significant difference (RR = 0.969) in vaccination status before and
after the intervention (Table 4.3). There was one participant (1.9%) who declined to answer the
vaccination status question at the 4-week follow-up. Thus, there were 50 participants (92.6%)
who remained unvaccinated against COVID-19 after exposure to the intervention of the EBP
project (Figure 4.1).
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Table 4.3
Relative Risk
Vaccinated

Not Vaccinated

Pre-intervention

96

54

Post-intervention*

99

50

*One person declined to report vaccination status
Relative Risk (RR) =

!"#!$%"#% !"#$ !"#$% !"#$%!& !"#$%
!"#!$%"#% !"#$ !"#$% !"# !"#$%!& !"#$%

37

=

!
!!!
!
!!!

=

!"
!"!!"
!!
!!!!"

=

!"
!"#
!!
!"#

=

!.!"
!.!!

= 0.969

CHAPTER 5
DISCUSSION
The EBP project evaluated the effectiveness of a multimodal intervention aimed at
decreasing vaccine hesitancy and increasing uptake of the COVID-19 vaccine in the family care
setting. The intervention was created by the DNP student and implemented by staff in the clinic,
with oversight and guidance by the DNP student. Effective interventions to improve vaccine
uptake are needed in the family care setting and can be created and utilized by doctorally
prepared advanced practice nurses. Findings of the EBP project will be discussed in this
chapter.
Explanation of Findings
The outcome of interest for this EBP project was uptake of the COVID-19 vaccine in the
family care setting. Participants who had not received the COVID-19 vaccine were exposed to
the multimodal intervention while visiting the clinic for a scheduled appointment. The vaccine
statuses of the participants were evaluated 4-weeks later by either looking in the EMR if the
data was available or calling them to inquire their current vaccination statuses. These results
were documented and analyzed to measure the effectiveness of the intervention. This EBP
project found a 5.6% increase in the COVID-19 vaccination rate among participants 4-weeks
after being exposed to the multimodal intervention. Although there was an increase in
vaccination rate, the increase was not large enough to represent a statistically significant result.
The lack of statistically significant results of this EBP project are not congruent with the
best evidence found in the literature used to support this project. Prior to the creation and
implementation of this EBP project, a review of literature was performed to find best practice
regarding decreasing hesitancy and increasing uptake of the COVID-19 vaccination. Due to the
new nature of the COVID-19 virus and vaccination, the availability of high level, strong evidence
was limited. However, the literature was saturated with evidence regarding addressing vaccine

38

hesitancy and uptake of other vaccinations, such as influenza, human papillomavirus, and
pneumococcal. Thus, the literature search primarily focused on interventions utilized by HCPs
in the primary care setting to decease vaccine hesitancy and increase immunization uptake.
Effective interventions included written patient reminders (Canadian Paediatric Society, 2018;
Jaca et al., 2018; Jacobson Vann et al., 2018; Khanh-Dao Le, 2021; NICE, 2018; Sanftenberg
et al., 2019; Thomas & Lorenzetti, 2018), electronic patient reminders (Canadian Paediatric
Society, 2018; Jaca et al., 2018; Jacobson Vann et al., 2018; Khanh-Dao Le, 2021; NICE, 2018;
Sanftenberg et al., 2019; Thomas & Lorenzetti, 2018), patient education (Jaca et al., 2018;
Kaufman et al., 2018; NICE, 2018; Reno et al., 2018; Sanftenberg et al., 2019; Thomas &
Lorenzetti, 2018), and provider education (Jaca et al., 2018; NICE, 2018; Reno et al., 2018;
Sanftenberg et al., 2019). These effective interventions provided the foundation for the creation
of the multimodal intervention used in this EPB project to decrease hesitancy and increase
uptake of the COVID-19 vaccine.
The difference between the results of this EBP project and the best practice according to
the current literature can be explained by several different possibilities. The first, and possibly
the most significant, reason being that this EBP project was based upon evidence regarding
vaccines other than the COVID-19 vaccine, such as influenza, human papillomavirus, and
pneumococcal. There was a plethora of evidence in the literature that provided interventions to
decrease vaccine hesitancy or increase uptake of these different vaccines, such as written and
electronic patient reminders and patient and provider education. However, there was very
limited evidence regarding the COVID-19 vaccine and effective interventions of increasing its
uptake. This finding was due to the newness of the COVID-19 vaccine at the time of the
literature review, which was conducted in June 2021. At that time, the COVID-19 vaccines had
only been authorized for emergency use, as approved by the U.S. Food and Drug
Administration (FDA), for 6 months. This short time span did not allow for research to have
been performed, completed, and published, especially higher levels of evidence, such as
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evidence summaries, CPGs, and systematic reviews. Thus, the EBP project spawned from the
assumption that the COVID-19 vaccine was similar to other vaccines being administered in the
family care setting, such as influenza, human papillomavirus, and pneumococcal. In addition, it
was presumed that effective interventions found in the literature used to decrease vaccine
hesitancy and increase uptake of other common vaccines could be appropriately and
successfully utilized in this EBP project for the COVID-19 vaccine. However, the findings of this
EBP project do not support this supposition.
Another explanation for the incongruent findings of this EBP project with the evidence
from the literature is the novelty of the COVID-19 vaccine at the time of the project
implementation. The first case of COVID-19 was identified and confirmed in the United States
on January 18, 2020 (CDC, 2022 January 5). Eleven months later, on December 11, 2020, the
first COVID-19 vaccine, created by Pfizer-BioNTech, was issued an Emergency Use
Authorization (EAU) by the FDA (CDC, 2022 January 5). A few days later, on December 18,
2020, the FDA issued an EAU for the second COVID-19 vaccine, created by Moderna, and
again on February 27, 2021, for the third COVID-19 vaccine, created by Johnson and Johnson
(CDC, 2022 January 5). The EUA of these vaccines confirms they have met the safety,
efficacy, and manufacturing quality set forth by the FDA, but have not gone through the formal
approval process of the FDA. However, on August 23, 2021, the FDA formally approved the
Pfizer-BioNTech COVID-19 vaccine for persons over 16 years of age (U.S. Food and Drug
Administration, 2021, August 23). Therefore, during the implementation period of this EBP
project, one of the COVID-19 vaccines had official FDA approval and the other two had been
approved for emergency use, and all three of the vaccines had been available to the public for
less than one year. This newness of the COVID-19 vaccine raised many questions for
recipients regarding short and long-term safety, efficacy, and side effects, to which there was
limited clinical evidence to answer these questions. In addition, many people were nervous and
skeptical of the short timeline in which the COVID-19 vaccine was created and distributed,
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despite receiving an EUA from the FDA, which ensures the safety, efficacy, and quality of the
vaccine. According to tradition, many people fear the unknown and have difficulty accepting
things that are new, and thus this may have negatively influenced participants’ willingness to
receive the novelty COVID-19 vaccine.
A final possible reason for the inconsistent findings between this EBP project and the
best evidence from the literature is the public perception of the COVID-19 vaccine amid a global
pandemic. Those who were present to experience the COVID-19 pandemic unfold can bear
witness to the plethora of information that was being broadcasted daily by the media on
television, the Internet, and social media. Although these sources can be informative outlets
used to notify the public of new discoveries and information, they can also be a platform for
rumors and conspiracy theories to spread, which can pollute public perceptions. Islam et al.
(2021) explored media content during the pandemic and discovered that 91% of the 637
COVID-19 vaccine related items discovered were rumors related to vaccine development,
availability and access (36%), morbidity and mortality (20%), safety, efficacy, and acceptance
(8%), and other categories (36%), and the remaining 9% of the items were conspiracy theories.
In addition, of the 637 COVID-19 vaccine-related items that were investigated, 5% were found
to be true, 83% were false, 10% were misleading, and 2% were exaggerated (Islam et al.,
2021). Misinformation provided to the public can cause detrimental effects to not only their
perceptions, but to their overall health by believing it. Hearing statements on the news or
reading a social media post about potential side effects of the COVID-19 vaccine, such as
causing infertility or permanently altering DNA, despite being untrue, incites fear and mistrust.
In addition, hearing claims about potential political or economic interests of the COVID-19
vaccines and their development can cause people to be weary and potentially refuse the
vaccine, despite its true safety and efficacy. Thus, these negative public perceptions of the
COVID-19 vaccine may have contributed to the incongruent results of this EBP project with the
evidence from the literature.
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At the time of the creation and development of this EBP project, there were no data
evaluating the topic of the COVID-19 vaccine and effective interventions to decrease hesitancy
and increase its uptake. However, 9 months later, at the conclusion of the project, new
literature searches using the same search methods from the beginning of the project were
performed to evaluate the new data. A new literature search conducted in JBI produced 44 new
pieces of evidence, with one of them being relevant to this EBP project (Whitehorn, 2022).
There were no new high-level pieces of evidence that addressed COVID-19 directly; however,
there were two new systematic review protocols that did. A new literature search conducted in
Cochrane Library resulted in 3 new Cochrane reviews, with 2 of those being relevant to this
EBP project (Cooper et al., 2021a; Glenton et al., 2021). However, none of the new results
addressed COVID-19 specifically. A new literature search conducted in TRIP produced 36 new
guidelines, with 5 of them being relevant to this EBP project (ECDC, 2021 June; ECDC, 2021
September; ECDC, 2021 October 15; ECDC, 2022; WHO, 2021). There were almost 50 new
guidelines concerning COVID-19 available on TRIP, but they mostly concerned current
vaccination recommendations, especially for vulnerable populations such as pregnant and
lactating women, immunocompromised individuals, and those people with cancer. A new
literature search conducted in CINAHL resulted in 21 new pieces of evidence, with 8 of them
being relevant to this EBP project (Eisenhauer et al., 2021; Gurfinkle et al., 2021; Lerner et al.,
2021; Mical et al., 2021; Rand, 2022; Rosas et al., 2022; Talmy et al., 2021; Taylor et al., 2021).
One of those relevant pieces of evidence directly addressed the COVID-19 vaccine (Talmy et
al., 2021) while the other focused on other routine vaccines. Of the 21 total new pieces of
evidence, 5 of them were concerned with COVID-19, which was substantially more than the
original search at the beginning of this EBP project. A new literature search in Medline elicited
37 new pieces of evidence, with 5 of them being relevant to this EBP project, but only 3 of them
were unique to the overall literature review (Cooper at al., 2021b; Islam et al., 2021; Singh et al.,
2021). All three of these new, relevant pieces of evidence were related to the topic of the
42

COVID-19 vaccine. Of the 37 total pieces of evidence produced in the new literature search, 7
of them concerned the topic of COVID-19. These new literature searches show the increase in
number of relevant pieces of evidence to this EBP project and the growth of information about
the COVID-19 vaccine. These new pieces of evidence could affect the development,
implementation, and evaluation of this EBP project if conducted in the future versus the year it
actually occurred.
Strengths and Limitations of the DNP Project
Strengths
Upon evaluation and reflection of this EBP project, it is concluded that there were
several strengths. One of the most significant of these strengths is that in the midst of one of
the worst global pandemics in history, decreasing hesitancy and increasing uptake of the
COVID-19 vaccine was a much-needed health prevention topic that needed implemented and
promoted. The COVID-19 virus has infected millions of people and killed hundreds of
thousands of them, but the rates of confirmed cases and deaths have slowed since the
discovery of the vaccine (CDC, 2022 April 27). As more people have received the COVID-19
vaccine, the numbers of confirmed cases and deaths have continued to decline, which could
ultimately bring an end to the catastrophic pandemic. It is the duty of HCPs to educate their
patients and encourage them to receive the COVID-19 vaccine to not only protect themselves,
but also those around them. Primary health prevention, which includes immunizations, is a
specialty for NPs and they should therefore promote the COVID-19 vaccine in their practice. As
doctorally prepared NPs, evidence-based interventions should be used to promote the uptake of
the COVID-19 vaccine and decrease vaccine hesitancy among patients, such as the objective
of this EBP project. Thus, the need for this EBP project was significant and further work about
the topic needs to be completed.
Another strength of this EBP project was the appealing and professional creation and
execution of the multimodal intervention. Much time was spent conducting research and
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gathering the most current evidence and statistics to be used in the intervention. This
information was updated constantly to ensure it was accurate. The PowerPoint presentation
used for the provider education session (Appendix B) and the informational brochures that were
handed out to patients (Appendix C) included information regarding the COVID-19 vaccine,
such as current recommendations, safety, efficacy, benefits, side effects, and contraindications.
The PowerPoint presentation also included information regarding vaccine hesitancy and
effective strategies of working with patients who were vaccine hesitant. The patient reminder
cards (Appendix D) contained information about the cost of the COVID-19 vaccine, as well as
where to receive the vaccine and how to schedule an appointment to do so. These materials
were created in a meticulous and professional manner, to provide reliable and trustworthy
information to the participants. Many compliments were received on the appealing look of the
materials, as well as the thoroughness of the provided information. There was much positive
feedback on the entirety of the multimodal intervention and its implementation in this EBP
project.
Limitations
Although there were several strengths of this EBP project, there were also numerous
limitations that were encountered during the development, implementation, and evaluation of
the project. First and foremost, information regarding the COVID-19 vaccine, including
recommendations and availability, was constantly changing during the entirety of the project,
making it difficult to stay current. For example, the informational brochures had to be updated,
reprinted, and redistributed once during the implementation period when the minimum age of
receipt was lowered from 12 years of age to 5 years on November 2, 2021 (CDC, 2022, January
5). Not only was this time consuming to have to change the informational brochures and
replace them at the clinic, but it was also expensive to cover the reprinting costs.
Another limitation of this EBP project was the difficulty in overseeing its execution on a
daily basis. Once the multimodal intervention was created, the staff at the clinic was
44

responsible for ensuring the participants were all exposed to it. The DNP student checked in as
much as possibly, minimally on a weekly basis, but was unable to be there daily. At one point
during the implementation phase, the medical assistants were found to have placed the
informational brochures and patient reminder cards on the desk rather than handing them to
each patient upon check-in, as originally planned. The purpose of physically handing the
materials to the patients was to ensure each patient was properly exposed to the multimodal
intervention. With the materials simply sitting on the check-in counter, some patients may not
have seen them or cared to take one. This may have limited intervention exposure and possibly
positive reception of the COVID-19 vaccine by some patients of the sample population. The
DNP student did adapt the process by speaking to staff and informing them of the desired
method of material distribution. However, it is unclear how many participants did not receive an
informational brochure or patient reminder card in the meantime.
Yet another limitation of this EBP project was the lack of funding necessary to execute
the original intervention as planned. According to the best evidence in the literature, the patient
reminder cards should have been mailed to the residence of the patients. Receiving the
reminder card away from the clinic would have allowed another opportunity for the patients to
receive the COVID-19 vaccine information and also serve as a reminder for them to get
vaccinated. Unfortunately, the printing and postage cost was too expensive for the DNP student
and the clinic was unable to provide the funding. Therefore, the distribution of the patient
reminder cards was adapted from what was found in the literature to what was performed in the
clinical setting for this EBP project.
A final limitation of this EBP project was the timing of the implementation period and the
mindsets of the participants at that point in time. People in the U.S. began receiving the
COVID-19 vaccine in December 2020 after it was approved by the FDA (CDC, 2022 January 5).
The vaccines were initially given to adults over 65 years and frontline workers, and then slowly
were administered to people in descending age groups until finally, months later, all people over
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16 years were able to receive the COVID-19 vaccine. At the time of the creation and
development of this EBP project, in June 2021, there was a significant number of people who
were vaccine hesitant and had not yet received the COVID-19 vaccine. This knowledge helped
motivate staff about this EBP project and support its need in the clinical setting. However, after
months of research and development, this project was not ready for implementation until
October 2021. By this time, many of the vaccine hesitant people had made up their minds: (a)
they had either chosen to receive the COVID-19 vaccine, and had done so, or (b) they had
opted not to do so. From the 4-week follow-up telephone calls made, it seemed that many of
the participants who had not yet received the COVID-19 vaccine were not inclined to do so.
Furthermore, some of the participants were perceived as slightly rude and aggressive when
declaring their negative COVID-19 vaccination status. After reflection on this EBP project, it
seems that if it could have taken place a few months earlier it may have had a different overall
result and potentially more positive impact.
Despite the low vaccination rate and limitations, three individuals did receive the
vaccine. While one cannot be sure that the intervention was the reason for that outcome, the
health risks associated with COVID-19 were significantly reduced and hold clinical significance
for those individuals.
Sustainability
Due to the constant changing and updating of current recommendations and availability
of the COVID-19 vaccine, this EBP project could not be sustained at the clinical site. Research
about COVID-19 and the vaccine is being conducted, published, and distributed continuously.
This leads to new evidence, new recommendations, and new policies. Although this is a
positive development for the COVID-19 pandemic and vaccine, it makes this EBP project nearly
impossible to sustain at this time. The providers at the clinic, informational brochures, and
patient reminder cards would need to be updated and reprinted constantly to stay current and
accurate. Thus, staff at the clinic and funds from the larger organization would need to be
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involved in the sustainability of this EBP project, which was unfortunately not possible at this
time.
Relevance for EBP Model
The Iowa Model-Revised (Iowa Model Collaborative, 2017) served as the framework for
this EBP project and was tremendously helpful in guiding its development, implementation, and
evaluation. The Iowa Model-Revised consists of seven sequential steps, with an additional
three critical decision points and corresponding feedback loops that allows for adjustments and
reevaluation as needed throughout the EBP process. The initial step, or identifying triggering
issues/opportunities, motivated the review of literature for current issues, as well as inquiring at
the clinical site for potential opportunities. This resulted in the selection of the topic of
decreasing hesitancy and increasing uptake of the COVID-19 vaccine in the family care setting,
which constitutes step two in the model. The first critical decision point, which asks if the topic
is a priority, was easy to affirm at the time due to the current COVID-19 pandemic. The next
two steps of the model, which are forming a team and assembling, appraising, and synthesizing
the body of evidence, were easily achieved. Although there was not much evidence regarding
the COVID-19 vaccine specifically, there was plenty of evidence regarding vaccine hesitancy
and interventions of increasing uptake of other routine vaccines, which was utilized, achieving
the second critical decision point. The fifth step of the model, which is designing and piloting the
practice change, was completed, however the next and final critical decision point was where
this EBP project came to a halt. Unfortunately, this EBP project showed that the change was
not appropriate for adoption in practice, due to the insignificant results, and thus the feedback
loop for considering alternatives and redesign needed to be utilized. Thus, the final steps of the
model, integrating and sustaining the practice change and disseminating the results, were not
used. However, the advantage of using this model is the feedback loops, which allow changes
to be made to the EBP project, which could potentially improve it and make it successful and
more sustainable.
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Recommendations for the Future
Although this EBP project showed results that were not statistically significant (R =
0.969) in decreasing vaccine hesitancy and increasing uptake of the COVID-19 vaccine in the
family care setting, much was learned from the development, implementation, and evaluation of
the project.
Research
A thorough review of literature at the beginning of this EBP project revealed a plethora of
information regarding interventions to decrease vaccine hesitancy and increase uptake of
routine vaccines, such as influenza, human papillomavirus, and pneumococcal. However, at
the time of this project, there was no evidence about the effectiveness of these interventions on
the hesitancy and uptake of the COVID-19 vaccine. Therefore, future research is needed for
evaluating interventions used to decrease hesitancy and increase uptake of the COVID-19
vaccine specifically. The literature searches that were repeated at the conclusion of this EBP
project revealed new evidence regarding the COVID-19 vaccine, which is what is needed. As
time continues to go on, more research and evidence is needed to strengthen the interventions
and reliability of using them.
Education
Primary prevention, which includes immunizations such as the COVID-19 vaccine, is a
significant component of care provided by registered nurses and NPs and is heavily
emphasized during their education and preparation. Immunizations and other primary
prevention strategies promote health of individuals in the community and limit the onset and
progression of different diseases. Improving health of individuals not only increases patient
outcomes and satisfaction, but also leads to cost effectiveness in the healthcare setting. This is
advantageous for all parties involved, including patients and HCPs. Thus, effective
interventions are needed to effectively decrease vaccine hesitancy and increase uptake of the
COVID-19 vaccine. These interventions will be helpful for nurses and other HCPs to use in
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clinical practice to promote the health of their patients and protect them from the deadly COVID19 virus.
Conclusion
Since December 2019, COVID-19 has become one of the worst pandemics in history,
infecting and killing billions of people around the world (WHO, 2021). However, the rates of
confirmed cases and deaths have slowed since the discovery of the COVID-19 vaccine (CDC,
2022 April 27) and therefore show a need for widespread vaccination. The purpose of this EBP
project, which was guided by the Iowa Model-Revised (Iowa Model Collaborative, 2017), was to
decrease vaccine hesitancy and increase uptake of the COVID-19 vaccine in the family care
setting. A multimodal intervention was created based upon current literature and consisted of
an educational session with HCPs in the clinic, informational brochures, and vaccine reminder
cards given to patients during their visits to the clinic. This EBP project was implemented over a
10-week time period in a Northern Indiana family care clinic and all adults 18 years of age and
older who sought care in the clinic were exposed to the intervention. The outcome of interest
was COVID-19 vaccination status and was assessed by reviewing electronic chart records and
making telephone calls to the participants. The EBP project found a 5.6% increase in the
COVID-19 vaccination rate among participants four weeks after being exposed to the
multimodal intervention, which represented a non-significant result. Future research is needed
to identify and evaluate effective interventions aimed at decreasing vaccine hesitancy and
increasing uptake of the COVID-19 vaccine in the family care setting. Promoting primary
prevention strategies, such as immunizations, is a significant responsibility of the DNP prepared
NP to improve the health statuses of patients and reduce the disease burden in communities.
Creating and implementing effective interventions to decrease vaccine hesitancy and increase
vaccine uptake of different vaccines, especially the COVID-19 vaccine during this terrible
pandemic, can accomplish this.
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Appendix A
Evidence Table
Lead Author/
Year/Quality

Purpose/
Design/Sample

Interventions

Measurement/
Outcomes

Results/
Findings

Strengths/
Limitations

Patient reminder and recall
interventions should be used
to increase vaccination rates.

The systematic
review included a
large number of high
quality studies,
which result in
strong conclusions.
It showed that the
interventions
positively impact
vaccination rates
and applies to
infants, children,
adolescents, and
adults.

Level I Evidence
Long KhanhDao Le
2021

Purpose was to find the
best evidence to improve
immunization rates using
patient reminder and
recall interventions.

High quality
Design was an evidence
summary and the sample
was an RCT and a
systematic review of 75
RCTs, non-randomized
CTs, and interrupted time
series.

Madhava Sai

Purpose was to find the

Patient
reminders
and recall
interventions
(i.e. telephone
calls, letters,
postcards,
text
messages,
autodialers, or
combinations
of the above)

Information

Vaccination
rates

Types of reminder and recall
interventions should be
personalized for specific
providers, clinics, and
patients.
Single interventions, such as
telephone or letter reminders,
are preferred over
combination interventions.

The views and

59

(Khanh-Dao Le, 2021)

However, the RCT
of approximately
15,000 adults
showed no
improvement in
vaccination rates
when using the
interventions.

Vaccination information

Although qualitative

Sivapuram
2021
High quality

best evidence concerning
parents and informal
caregivers’ opinions on
childhood vaccination
information content.
Design was an evidence
summary and the sample
was a systematic review
of 38 qualitative studies,
a qualitative study, and a
cross-sectional study.

Jessica
Kaufman
2018
High quality

Purpose was to evaluate
the effects of
educational, face-to-face
interventions about
childhood vaccinations
on vaccination rates,
intent to vaccinate, and
knowledge and beliefs of
parents.

content of
routine
childhood
vaccinations
presented to
parents and
informal
caregivers

experiences of
parents and
informal
caregivers.

should be evidence-based,
easy to comprehend,
personalized to the patient,
and include the benefits,
risks, side effects,
ingredients, safety, technical
information, and reasons for
vaccination.
(Sivapuram, 2021)

Face-to-face
information or
education
discussions

Vaccination
rates, intent to
vaccinate, and
knowledge,
attitudes and
beliefs of
parents.

Face-to-face information or
education interventions can
improve vaccination status,
parents’ understanding of
vaccination, intent to
vaccinate, and, to a lesser
degree, parents’ attitudes and
beliefs about vaccination.
(Kaufman et al., 2018)

60

studies are lower
levels of evidence
than quantitative,
they offer
descriptive insights
to lived experiences
of participants,
which can provide
important
information that can
only be attained in
this manner.
The systematic
review is strong,
however its focus
was on routine
childhood
vaccinations and the
participants were
parents, which could
be a limitation to its
generalizability to
the adult population
regarding
vaccinations.
The article is a
systematic review of
RCTs, which make
it a strong, highlevel piece of
evidence.
According to the
review, the RCTs
were deemed to

Design was a systematic
review and the sample
consisted of 7 RCTs and
3 cluster RCTs.

Roger E.
Thomas
2018
High quality

Purpose was to evaluate
different interventions
used to increase uptake
of the influenza
vaccination in people
over 60 years of age in
the community.
Design was a systematic
review and the sample
consisted of 61 RCTs.

Interventions
of interest
were those
that increase
uptake of the
influenza
vaccination,
specifically
those that
increase
community
demand,
vaccination
access, and
provider
activity

Vaccination
rates

Effective interventions found
to increase community
demand for vaccination
include reminder letters and
leaflets, education by nurses
or pharmacists, nurses
vaccinating patients, and
client outreach by retired
nurses, teachers,
receptionists, and medical
students.
Effective interventions found
to improve vaccination
access include home visits,
client group clinic visits, and
free vaccine offers.
Effective interventions found
to improve vaccination
delivery by healthcare
providers include physician
payment, physician
reminders, posters in the
clinic promoting physician
competition, and chart
reviews declaring current
vaccination rates of the
physicians.
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have moderate to
high risk of bias due
to their study
designs, which
negatively affect the
quality of the review
as a whole.
The quality of
evidence was rated
as high to moderate
and there was only
a moderate risk of
bias, which makes
this a strong piece
of evidence.
The population of
interest was adults
over the age of 60
years, which limits
generalizability to
those adults aged
18-59 years, which
is much of the adult
population.

Julie C.
Jacobson
Vann
2018
High quality

Purpose was to assess
different types of patient
reminder and recall
interventions effect on
vaccination rates.

Patient
reminders
and recall
interventions

Vaccination
rates

Design was a systematic
review and the sample
consisted of 75 studies,
both RCTs and nonrandomized CTs.

(Thomas & Lorenzetti, 2018)
Patient reminders via
telephone and autodialer
calls, text messages, and
letters or postcards increase
vaccination rates.
Combinations of the above
patients reminders are also
effective at increasing
vaccination rates.
Telephone reminders were
the most effective at
increasing vaccination rates.
(Jacobson Vann et al., 2018)

Canadian
Paediatric
Society
2018
High quality

Purpose was to provide
best evidence on how to
address vaccine
hesitancy and improve
vaccination uptake in
vaccination programs,
clinics, and office
practices.

Interventions
to address
vaccine
hesitancy and
improve
vaccination
uptake.

Vaccine
hesitancy
Vaccination
rates

62

Steps to address vaccine
hesitancy and improve
vaccination uptake in
vaccination programs, clinics,
and office practices include:
1. Detect and address
vaccine-hesitant
subgroups

The systematic
review included
many different
interventions to
increase vaccination
rates, which
provides many
different options to
use in the clinical
setting.
The studies in the
review consisted of
many different
settings (state
health departments,
private practices,
schools, and rural
areas) and
populations (infants,
children,
adolescents, and
adults), which
increase the
generalizability of
the results and
conclusions.
The guideline
provides specific,
easy to use,
stepwise
instructions to
address vaccine
hesitancy.

2. Educate health care
providers involved
with immunization on
best practices
3. Utilize evidence-based
strategies known to
increase vaccine
uptake
4. Educate children,
youth and adults on
the importance of
immunization for
health
5. Work collaboratively

Design was possibly a
narrative review. There
were no details on how
the review was
constructed or what the
sample population was.

National
Institute for
Health and
Care
Excellence
(NICE)

Purpose was to provide
guidance on how to
increase uptake of the
influenza vaccination.
Design was a clinical
practice guideline.

Interventions
of interest
include those
that increase
uptake of the
influence
vaccination

Vaccination
rates

2018

(Canadian Paediatric Society,
2018)
Recommendations:
1.1.1: “Use a multicomponent
approach to develop and
deliver programmes to
increase flu vaccination
uptake” (p.6)
1.1.2: “Providers of the flu
vaccination should work
together with other agencies
to develop programmes to
increase vaccination uptake”
(p.6)

High quality

1.2.1: “Educate health and
social care staff, particularly
those in contact with eligible
groups, about flu vaccination”
(p.6)

63

The guideline is
presented as a
narrative review,
which is a low level
of evidence.
There were no
details on how the
review was
constructed, which
decreases the
quality appraisal of
the piece of
evidence.

The guideline is
written by a
reputable
organization and is
extremely thorough,
which contribute to
the piece of
evidence being very
strong and a high
level of evidence.
The guideline offers
recommendations
for increasing
vaccination rates via
many different
avenues, settings,
and populations,
which make it very

1.2.2: “Provide information on
the following as part of an
education proramme on flu
vaccination for health and
social care staff: Who is
eligible for free flu vaccination
and where to get it, benefits
of vaccination, how flu is
transmitted, how the flu
vaccine is given,” etc. (p.7)
1.2.3: “Explain to health and
social care staff how they
can: identify people who are
eligible [and] make the most
of opportunities to raise
awareness about and offer flu
vaccination to eligible groups”
(p.7)
1.2.4: “Health and social care
staff who are in direct contact
with eligible groups should:
include training on flu and flu
vaccination as part of their
continuing professional
development plan [and] be
able to provide tailored
information on the risks and
benefits of flu vaccination,
and be able to offer and
administer it” (p.8)
1.2.5: “Raise awareness of
free flu vaccination among

64

applicable and
generalizable.
The design and
creation of the
guideline is
thoroughly
explained, which
make the piece of
evidence appraised
as strong and of
high quality.
The guideline is
lengthy and it
requires a
significant amount
of time to read and
comprehend all the
recommendations.

people who are eligible” (p.8)
1.2.6: “Consider working with
statutory and voluntary
organistations, including
those representing people
with relevant medical
conditions, to increase
awareness of flu vaccination”
(p.8)
1.2.7: “Give people who are
eligible face-to-face brief
advice or a brief intervention
on the importance of flu
vaccination” (p.8)
1.2.8: “Explain to parents or
carers that the nasal spray is
recommended for eligible
children from the age of 2
years” (p.9)
1.2.9: “Give people
information about the location
and opening hours of relevant
flu vaccination services” (p.9)
1.2.10: “Include information
on flu vaccination with other
health-related messages and
existing health-promotion or
vaccination programmes for
people in eligible groups”
(p.9)
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1.3.1: “Use every opportunity
throughout the flu vaccination
season to identify people in
eligible groups and offer them
the flu vaccination” (p.9)
1.3.2: “Establish and use links
with statutory and voluntary
organisations that work with
carers, looked-after children
and young people or other
groups, to identify eligible
people who have not been
vaccinated “ (p.10)
1.3.3: “Provide multiple
opportunities and routes for
eligible people to have their
flu vaccination at a time and
location convenient to them”
(p.10)
1.3.4: “Consider outreach
opportunities for underserved
groups in line with local
practice and patient group
directions arrangements”
(p.10)
1.3.5: “Consider providing
evening and weekend
services in primary care,
including community
pharmacy, to deliver flu
vaccination to people who
may find it difficult to attend at
other times” (p.10)
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1.3.6: “Use clinical systems to
identify eligible groups and
work out supply
requirements” (p.10)
1.4.1: “Inform and invite
children and adults in eligible
groups for flu vaccination
during face-to-face
interactions, whenever the
opportunity arises” (p.11)
1.4.2: “Advise parents of all
children aged 2 and 3 years
who are covered by the
universal vaccination
programme, and children
aged 6 months and over who
are in a clinical risk group
about the benefits of flu
vaccination” (p.11)
1.4.3: “When inviting people
for flu vaccination: ensure the
invitation comes from a
healthcare practitioner that
they know […], tailor it to the
person’s situation […],
include information about the
risks of not being vaccinated,
include educational
messages to help overcome
barriers to accepting the offer
of a vaccination” (p.11)
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1.4.4: “Use written materials
(including text messages,
letters and email), phone calls
from staff or an auto dialer,
social media, or a
combination or methods, to
contact people in eligible
groups whose immunizations
are due or overdue” (p.11)
1.4.5: “For invitations and
reminders using digital media:
link to further information on
trusted websites and enable
the person to ask for further
information, provide a prompt
so the person can make an
appointment online, and
encourage people to find out
more during face-to-face
interactions, such as with
their health visitor or
pharmacist” (pp.11-12)
1.4.6: “Consider using peerled approaches for inviting
people in underserved groups
who are eligible for flu
vaccination” (p.12)
1.4.7: “Consider providing flu
vaccination during routine
appointments in specialist
clinics to people who are at
high risk from flu and its
complications” (p.12)
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1.4.8: “When the opportunity
arises, for example when
people attend routine hospital
appointments, identify anyone
in a clinical risk group who
has not been vaccinated and
offer them a flu vaccination”
(p.12)
1.4.9: “When offering people
the flu vaccination: make the
offer face-to-face if possible,
use positive messages to
encourage people to have the
vaccination […], tailor
information to the person’s
situation […], ensure
information is simple, easy to
read and provides a
consistent message about flu
and flu vaccination, ensure a
healthcare practitioner they
know offers the vaccination,
and make it easy for the
person to get the vaccination”
(p.12)
1.4.10: “Include prompts
about people’s eligibility for
flu vaccination in electronic
patient records or in medical
notes” (p.13)
1.5.1: “Healthcare providers
should keep patient records

69

up to date and accurate to
help identify people who have
not been vaccinated and are
eligible for flu vaccination that
season” (p.13)
1.5.2: “Providers of flu
vaccination should record
uptake rates” (p.13)
1.5.3: “Commissioners and
providers should agree
approaches for sharing
information with general
practices about flu
vaccination given outside a
person’s own GP” (p.13)
1.5.4: “Use audit and
monitoring systems to give
providers of flu vaccination
regular feedback on
organizational progress
towards targets throughout
the immunization season”
(p.13)
1.5.5: “Commissioners should
raise awareness among
healthcare staff and providers
of flu vaccination about
enhanced services payments
and provider payments linked
to flu vaccination” (p.14)
1.5.6: “Commissioners should

70

ensure that providers flu
vaccination know that
submission of information on
flu vaccination directly affects
any linked organisational
incentive payments” (p.14)
1.5.7: “Commissioners should
highlight the need for audit,
monitoring and feedback of
flu vaccination given as part
of an incentive programme”
(p.14)
1.5.8: “Organisations
responsible for agreeing
quality indicators incentives
programmes should be aware
that revising target conditions
may encourage providers to
meet targets for flu
vaccination across all clinical
risk groups” (p. 14)
1.6.1: “When considering
increasing flu vaccination
uptake in carers who are not
otherwise eligible, use clinical
judgement” (p. 14)
1.6.2: “Providers of flu
vaccination, including primary
care staff and nurses working
in the community, could
consider: identifying and
offering eligible carers a flu

71

vaccination as the opportunity
arises [and] informing the
carers about other local
vaccination services if a
patient group direction or
enhanced service
arrangement has not been
agree with primary care
commissioners” (pp.14-15)
1.7.1: “Provide flu vaccination
to all front-line health and
social care staff who have
direct contact with patients or
clients” (p.15)
1.7.2: “Use audit and
monitoring systems to review
previous strategies and flu
vaccination uptake rates
among eligible staff and to
plan what methods to use to
increase uptake and manage
the supply for the next flu
season” (p.15)
1.7.3: “Consider the following
as part of a multicomponent
approach to increasing
uptake of flu vaccination
among front-line health and
social care staff: a full
participation vaccination
strategy, with nationally
agreed opt out criteria,
assigning dedicated staff to

72

increase awareness and
uptake, using local broadcast
media and social media,
getting and publicizing
support from high-profile
organizational leaders or staff
representatives, providing
information about the
effectiveness and safety of
the flu vaccine, using staff
incentives that fit with the
organization’s culture and the
values of the employees,
training peers to vaccinate
their co-workers, or to
encourage uptake and
challenge barriers, using
prompts and reminders in
various printed and digital
formats, and using systems
linked to named staff records
to monitor uptake and to
target prompts and
reminders” (pp.15-16)
1.7.4: “Consider prompting flu
vaccination to front-line health
and social care staff as a way
to protect the people they
care for, protect themselves
and their families, protect
their co-workers, and meet
professional expectations”
(p.16)
1.7.5: “Consider extending
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on-site vaccination clinic
hours to fit in with staff work
patterns, using outreach or
mobile services to offer flu
vaccination in areas and at
times where large numbers of
staff congregate, publicizing
information about mobile flu
vaccination services, and
offering opportunities for offsite and out-of-hours access”
(pp. 16-17)
1.7.6: “publicize flu vaccine
uptake rates and the
comparative performance of
individual departments or
sites within the organization
or locality” (p.17)
1.7.7: “Develop the flu
vaccination strategy in
conjunction with staff
representatives” (p.17)
1.7.8: “Agree approaches for
information sharing if off-site
access to flu vaccination is
offered to allow timely,
accurate and consistent
recording of people’s
vaccination status” (p.17)
(NICE, 2018)
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Anelisa Jaca
2018
High quality

Purpose was to evaluate
the effects on vaccination
uptake of different
interventions targeted at
reducing missed
opportunities for
vaccination (MOV).
Design was a systematic
review and the sample
consisted of 3 RCTs, 2
cluster randomized trials,
and 1 cohort study.

Interventions
used to
reduce MOVs
and increase
vaccination
rates.

Vaccination
rates
Rate of MOVs

Patient education, patient
tracking, outreach sessions,
and provider prompts
increased vaccination rates
and decreased MOV rates.
(Jaca et al., 2018)

These
interventions
could be
aimed at
recipients of
care,
providers of
care, or the
healthcare
system as a
whole.

The process for
searching, selecting,
reviewing, and
appraising studies
to include in the
systematic review
seems appropriate
and rigorous, which
results in a high
quality piece of
evidence.
The certainty of the
evidence was rated
moderate to low due
to the high risk of
bias and wide
confidence intervals,
which takes away
from the overall
quality of evidence.
Although the article
was a systematic
review, which is
high level of
evidence, it only
reviewed 6 studies,
which is a relatively
small number.
Fewer studies can
result in weaker
conclusions and
less applicability.
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Linda
Sanftenberg
2019
High quality

Purpose was to identify
and assess interventions
used to increase
influence vaccination
rates in chronically ill
patients in the primary
care setting.
Design was a systematic
review and the sample
consisted of 15 RCTs,.

Interventions
focused on
medical
personnel
(training
programs for
office teams,
reminder
systems for
physicians,
and extending
competence
of medical
professionals)

Vaccination
rates

Training programs for medical
personnel focused on
particular disease
management rather than
vaccination specifically can
improve vaccination rates.

The article is a
systematic review of
15 RCTs, which
provides a strong,
high level of
evidence.

Reminders systems for
physicians are effective at
improving vaccination rates
when generated for all eligible
patients.

The literature
search appears
rigorous, searching
many different
sources, such as
databases,
reference lists, and
gray literature, and
appraising for high
quality. The
supplemental
materials included
give a very thorough
description of the
search process.

Improving competence of
medical professionals can
improve vaccination rates.

Interventions
focused on
patients (text
message
reminders,
personalized
postcard
reminders,
letter
reminders,
educational
brochures,
and providing
financial
incentives)

Text message reminders
showed no greater benefit
than letters or postcards, but
all three were shown to
slightly increase vaccination
rates.
Personalized postcard
reminders improve
vaccination rates.
Providing financial incentives
had the greatest impact on
improving vaccination rates.
Personalized vs. nonpersonalized reminders are
preferred.

76

According to the
authors, there was a
possibility for
publication bias and
a ceiling effect,
which could
negatively affect the
quality and strength
of the article.

An educational element
added to patient reminders
showed no change in
vaccination rates.
(Sanftenberg et al., 2019)
Level II Evidence
Hanley J. Ho
2018
High quality

Purpose was to assess
the effect of point-of-care
interventions, such as
informational flyers and
posters, on the rate of
influenza and
pneumococcal
vaccination uptake.
Design was a clusterrandomized crossover
trial.
Sample was patients
over 65 years old who
visited one of the 22
selected clinics during
the study period.

Informational
flyers and
posters that
promoted the
influenza and
pneumococca
l vaccines

Primary
outcome was
change in
vaccination
rates.
Secondary
outcome was
identification of
other factors
associated
with
vaccination
uptake.

Distribution of informational
flyers and posters resulted in
a statistically significant
increase in both influenza and
pneumococcal vaccination
rates.
The interventions’ effect size
was larger for the
pneumococcal vaccination
compared to the influenza
vaccination.
A higher proportion of study
participants received both the
influenza and pneumococcal
vaccinations compared to
receiving just one of them.
Patients visiting the clinic for
follow-up of hypertension,
diabetes, and/or
hyperlipidemia were more
likely to receive the influenza
and pneumococcal
vaccinations.
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There was a wide
array of
demographics and
clinic locations in
the study, which
increases its
generalizability.
The interventions
were practical,
quick, and
inexpensive, which
make them more
desirable,
attainable, and
sustainable.
The study lacked
baseline vaccination
rates of the clinic.
Compliance of the
clinics with the
intervention were
not measured,
which would
ultimately affect the

(Ho et al., 2018)
Jenna A.
Reno
2018
High quality

Purpose was to explore
whether motivational
interviewing (MI) was
beneficial to healthcare
providers in
communicating with
parents of adolescents
who are hesitant to
receiving vaccinations.
Design was mixed
methods (qualitative and
quantitative) from an
original RCT.
Sample was parents of
patients from 8 clinics in
Colorado that
participated in the
intervention group of the
original RCT.

Motivational
interviewing

8 surveys were
sent via email
to be filled out
by providers
throughout the
intervention
period.
Outcomes of
interest
included:
1. Providers’
perceptions of
time spent
discussing
HPV vaccine
2. Providers’
perceptions of
self-efficacy
related to
communicating
about HPV
vaccine
3. Providers’
perceptions of
encountering
psychological
resistance
while
communicating
about HPV
vaccine
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MI, used during clinical visits,
did not increase time spent
discussing HPV vaccine or
overall office visit duration.
MI improved provider selfefficacy for discussing HPV
vaccine with vaccine-hesitant
parents.
MI was perceived by
providers as effective at
reducing resistance to HPV
vaccine in vaccine-hesitant
parents.
(Reno et al., 2018)

results and
conclusions of the
study.
The qualitative
aspect of the study
may be lower level
of evidence, but it
gives information
and themes that can
only be attained in
this manner, which
is very valuable.
The intervention,
use of MI, is very
difficult to measure.
For example, the
way the providers
speak, the words
they use, and how
often they used MI
could all vary
between providers.
This may skew the
results or end up
with bias.
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Provider Education PowerPoint Slides

EBP Project
A Multimodal Approach to
Decreasing Hesitancy and
Increasing Uptake of the Covid-19
Vaccine in the Family Care Setting

• Purpose: decrease vaccine hesitancy and
increase uptake of the Covid-19 vaccine using a
multimodal intervention
– Education and support provided to staff
– Paper reminders given to patients during office visit
– Informational brochures/posters around the clinic

• Chart reviews to assess pre and post
intervention Covid-19 vaccination rates

Meghan M. Zwierzynski, BSN, RN, DNP Student

Looking at the Numbers
United States

Indiana

Total # of Cases

44,857,861

1,000,163

Total # of
Deaths

723,205

15,771

Total # of Fully
Vaccinated

189,292,559

3,321,828

% Fully
Vaccinated

57%

50%

The Covid-19 Vaccines
• There are currently 3 vaccines that are
authorized and recommended in the U.S. to
prevent Covid-19:
– Pfizer-BioNTech: 2 shots given 3 weeks apart to
people 12 years and older
– Moderna: 2 shots given 4 weeks apart to people 18
years and older
– Johnson & Johnson: 1 shot given to people 18 years
and older
(CDC, 2021 September 1)

(CDC, 2021 October 19; Indiana Department of Health, 2021 October 19)

Covid-19 Vaccine Facts
• It is safe and effective
• It is recommended for ALL people 12 years of
age and older
Vaccinated

Unvaccinated

Less risk of illness

High risk of illness

Milder symptoms

Worse symptoms

Less risk of hospitalization

High risk of hospitalization

Less contagious

Highly contagious

From: https://www.facebook.com/StateHealthIN/photos/a.395188660531404/4552210441495851/

(CDC, 2021 August 16)
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Frequently Asked Questions

Vaccine Hesitancy

• Can you get Covid-19 from the vaccine?
– No, none of the vaccines contain the live virus that causes Covid-19.

• Are there side effects of getting the Covid-19 vaccine?
– There can be mild to moderate symptoms, such as soreness at the injection site,
headache, fatigue, fevers, and chills.

• Can you get the Covid-19 vaccine if you are pregnant or breastfeeding?
– Yes, it is actually encouraged, as studies show the Covid-19 antibodies can be given to the
baby and protect them.

• “Reluctance or refusal of vaccines despite the
availability of vaccine services” (WHO, 2019)
• One of the top 10 threats to global health
• Major reasons for Covid-19 vaccine hesitancy:
– Safety and efficacy concerns
– Preference for physiological immunity
– Distrust in government and health organizations
– Perceived breach on autonomy & personal freedom

• Will the vaccine hurt your chances of getting pregnant later in life?
– No, there is no evidence that the Covid-19 vaccine can cause infertility problems.

• Can you get the Covid-19 vaccine if you have underlying medical
conditions?
– Yes, it is very important for those people who have underlying medical conditions.

• Do you need the vaccine even if you already had Covid-19?

(American Academy of Family Physicians, 2021; WHO, 2019)

– Yes, it is possible to get re-infected with the Covid-19 virus. The vaccine offers further
immunity to the virus.
(CDC, 2021 September 9)

What is Our Role as
Healthcare Providers?

Combating Vaccine Hesitancy
1. Understand your
patients’ concerns
2. Ask why a patient is
hesitant
3. Counter any
misinformation
4. Know you are the
most trusted
information source
5. Tell patients they
need to get the
vaccine

6. Tailor your message
7. Address patients’ fears
about side effects
8. Prepare your staff to
answer questions
9. Show your vaccination
pride
10. Tell stories to make an
impact

•
•
•
•

Keep up-to-date with the facts
Spread awareness and knowledge
Be a patient advocate
Respect and support your patients

• https://www.cdc.gov/vaccines/covid-19/hcp/index.html
• https://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.html
• https://www.who.int/emergencies/diseases/novel-coronavirus-2019/
covid-19-vaccines/advice
• https://www.coronavirus.in.gov/vaccine/

(Henry, 2021)
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Appendix C
Informational Brochure

The Centers for Disease
Control and Prevention
(CDC) recommends the
Covid-19 vaccine for
ALL people 5 years of
age and older.

(From: https://www.coronavirus.in.gov/vaccine)

For more
information:
•
•
(From: https://health.clevelandclinic.org/should-i-get-the-vaccine-if-ive-already-hadcovid-19-and-would-my-side-effects-be-worse/)

•

Fully Vaccinated
Persons in
Indiana

•

https://www.coronavirus.
in.gov/vaccine/
https://www.cdc.gov/
coronavirus/2019ncov/vaccines/index.html
https://www.who.int/
emergencies/diseases/
novel-coronavirus 2019/
covid-19-vaccines/advice
Ask your clinical provider!


No
50.5%

The
Covid-19
Vaccine:
What You
Need to Know
Learn about the current
recommendations,
safety, effectiveness,
benefits, side effects,
frequently asked
questions and more!



Yes
49.5%

As of October 22nd, 2021
3,328,319 people in Indiana
are fully vaccinated.

(From: https://theconversation.com/new-covid-19-vaccine-warnings-dont-mean-its-unsafe-theymean-the-system-to-report-side-effects -is-working-164455)
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The Covid-19 vaccine is

(From: https://www.coronavirus.in.gov/2393.htm)

All three vaccines have met the U.S.
Food and Drug Administration’s (FDA)
standards for safety, effectiveness, and
manufacturing quality and
have been approved for
emergency use. On
August 23, 2021, the
FDA formally
approved the PfizerBioNTech vaccine for
anyone over 16 years of age.

From: https://wbc.net.au/covid19-vaccine-booking-information/

The Covid-19 vaccine is 95% effective.
There are currently three
vaccines approved &
recommended to prevent
Covid-19:
1. Pfizer-BioNTech: 2
shots given 3 weeks apart to
people 5 years and older
2. Moderna: 2 shots given
4 weeks apart to people 18
years and older

3. Johnson & Johnson:
1 shot given to people 18
years and older

Fully
Vaccinated

Not
Vaccinated

Less risk
of illness
Milder
symptoms
Less risk of
being in the
hospital
Less
contagious

High risk
of illness
Worse
symptoms
High risk of
being in the
hospital
Highly
contagious
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Frequently Asked
Questions
Can you get Covid-19 from the
vaccine?
No, none of the vaccines contain
the live virus that causes the
Covid-19 infection.
Are there side effects of getting
the Covid-19 vaccine?
There can be mild to moderate
symptoms, such as soreness at
the injection site, headache, and
fatigue.
Can you get the Covid-19
vaccine if you are pregnant or
breastfeeding?
Yes, it is actually encouraged, as
studies have shown that the
Covid-19 antibodies can be
passed to baby and protect them.
Can you get the Covid-19
vaccine if you have underlying
medical conditions?
Yes, it is especially important for
people who have chronic medical
conditions to protect them.
Do you need the vaccine even if
you already had Covid-19?
Yes, it is possible to get reinfected with the Covid-19 virus.
The vaccine offers further
immunity and protection.

Appendix D
Patient Reminder Card
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Appendix E
Data Collection Form #1

Participant #: ________________________

Participant #: ________________________

MRN #: ____________________________

MRN #: ____________________________

Age: _______________________________

Age: _______________________________

Gender: ____________________________

Gender: ____________________________

Race: ______________________________

Race: ______________________________

Vaccinated against COVID? YES or NO

Vaccinated against COVID? YES or NO

Participant #: ________________________

Participant #: ________________________

MRN #: ____________________________

MRN #: ____________________________

Age: _______________________________

Age: _______________________________

Gender: ____________________________

Gender: ____________________________

Race: ______________________________

Race: ______________________________

Vaccinated against COVID? YES or NO

Vaccinated against COVID? YES or NO

Participant #: ________________________

Participant #: ________________________

MRN #: ____________________________

MRN #: ____________________________

Age: _______________________________

Age: _______________________________

Gender: ____________________________

Gender: ____________________________

Race: ______________________________

Race: ______________________________

Vaccinated against COVID? YES or NO

Vaccinated against COVID? YES or NO
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Appendix F
Data Collection Form #2
Participant
Number

Week #

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2

Date of
Clinic Visit

Age (years)

Gender
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Race

COVID-19
Vaccinated at
Baseline?
(yes or no)

COVID-19
Vaccinated at
4-week
follow-up?
(chart review)

COVID-19
Vaccinated at
4-week
follow-up?
(phone call)

25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56

2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
4
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57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88

4
4
4
4
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
6
6
6
6
6
6
6
6
6
6
6
6
6

87

89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120

6
6
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8

88

121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150

9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
10
10
10
10
10
10
10
10
10
10
10
10
10
10
10
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Appendix G
Collaborative Institutional Training Initiative (CITI) program ethics training certificate

Completion Date 09-Apr-2021
Expiration Date
N/A
Record ID
42032409

This is to certify that:

Meghan Zwierzynski
Has completed the following CITI Program course:

Not valid for renewal of certification
through CME.

Group 1: Social Behavioral Educational Researchers
(Curriculum Group)

Group 1: Social Behavioral Educational Researchers
(Course Learner Group)

1 - Basic Course
(Stage)

Under requirements set by:
Valparaiso University

Verify at www.citiprogram.org/verify/?wd8cddf74-ef96-432f-8900-e97643070deb-42032409
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Appendix H
Data Collection Form #3

Participant #

Medical Record
#

Participant #

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39

41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
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Medical Record
#

40
Participant #
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Medical Record
#

Participant #

81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120

121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
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Medical Record
#

